INSECT SODIUM CHANNELS FROM INSECTICIDE-SUSCEPTIBLE AND INSECTICIDE-RESISTANT HOUSE FLIES

Abstract: The present invention is directed to isolated nucleic acid molecules encoding a voltage-sensitive sodium channel (VSSC) of Musca domestica, the VSSC being capable of conferring insecticide susceptibility or insecticide resistance to Musca domestica, as well as to the isolated voltage-sensitive sodium channels of Musca domestica encoded thereby. Nucleic acid molecules encoding insecticide susceptible VSSCs and nucleic acid molecules encoding insecticide resistant VSSCs are provided. Methods for increasing or decreasing the expression of functional voltage-sensitive sodium channels in host cells are also provided, as well as methods using the sodium channels. Also provided is a method for isolating other voltage-sensitive sodium channels.

Description: INSECT SODIUM CHANNELS FROM INSECTICIDE-SUSCEPTIBLE AND INSECTICIDE-RESISTANT HOUSE FLIES The subject matter of this application was made with support from the United States Government under USDA Grant No. 94-37302-0408. This application is a continuation-in-part of U.S. Serial No. 08/608,618, filed March 1, 1996, the contents of which are hereby incorporated by reference. FIELD OF THE INVENTION The present invention relates generally to insect sodium channel proteins, and more particularly to insecticide-susceptible and insecticide-resistant voltage- sensitive sodium channels of the house fly Musca domestica . BACKGROUND OF THE INVENTION Throughout this application various publications are referenced, many in parenthesis. Full citations for these publications are provided at the end of the Detailed Description. The disclosures of these publications in their entireties are hereby incorporated by reference in this application. Cell membranes must allow passage of various polar molecules, including ions, sugars, amino acids, and nucleotides. Special membrane proteins are responsible for transferring such molecules across cell membranes. These proteins, referred to as membrane transport proteins, occur in many forms and in all types of biological membranes. Each protein is specific in that it transports a particular class of molecules (such as ions, sugars, or amino acids) and often only certain molecular species of the class. All membrane transport proteins that have been studied in detail have been found to be multipass transmembrane proteins. By forming a continuous protein pathway across the membrane, these proteins enable the specific molecules to cross the membrane without coming into direct contact with the hydrophobic interior of the lipid bilayer of the plasma membrane. There are two major classes of membrane transport proteins : carrier proteins and channel proteins. Carrier proteins bind the specific molecule to be transported and undergo a series of conformational changes in order to transfer the bound molecule across the membrane. Channel proteins, on the other hand, need not bind the molecule. Instead, they form hydrophilic pores that extend across the lipid bilayer; when these pores are open, they allow specific molecules (usually inorganic ions of appropriate size and charge) to pass through them and thereby cross the membrane. Transport through channel proteins occurs at a much faster rate than transport mediated by carrier proteins. Channel proteins which are concerned specifically with inorganic ion transport are referred to as ion channels, and include ion channels for sodium, potassium, calcium, and chloride ions. Ion channels which open in response to a change in the voltage across the membrane are referred to as voltage-sensitive ion channels . The sodium channel is one of the most thoroughly characterized of the voltage-sensitive channels (see Fig. 1 for a model of a voltage-sensitive sodium channel) . In vertebrates, sodium channels in the brain, muscle, and other tissues are large membrane glycoprotein complexes composed of an alpha subunit (230-270 kDa) and 1-2 tightly associated smaller (33-38 kDa) beta subunits (reviewed by Catterall 1992) . The large alpha subunit forms the ion permeable pore while the smaller subunits play key roles in the regulation of channel function (Isom et al . 1992; reviewed by Isom et al . 1994) . The alpha subunit is common to purified channel preparations from Electrophorus electricus (electric eel) electric organ (Noda et al . 1984), rat brain (Noda et al . 1986), rat skeletal muscle (Barchi 1988) and chick heart muscle (Catterall 1986) . Other studies have revealed the existence of multiple closely related isoforms of the sodium channel found in different animal species, in different tissues within the same species, and even in the same tissue (Catterall et al. 1981; Frelin et al . 1984; Rogart 1986; Moczydlowski et al . 1986). The structure of invertebrate sodium channels is not as well defined. Gene cloning studies have established the existence of alpha subunits of structure similar to those described for vertebrates (Loughney et al . 1989; Ramaswami and Tanouye 1989; Okamoto et al . 1987) . Analysis of the para behavioral mutant (paralytic; Suzuki et al . 1971) of Drosophila melanogaster revealed that the para gene encodes a Drosophila sodium channel alpha subunit (Loughney et al . 1989) . The entire para cDNA sequence was determined (Loughney et al . 1989; Thackeray and Ganetzky 1994) . The kdr mutant of the house fly Musca domestica has also been studied. The kdr insecticide resistance trait of the house fly confers reduced neuronal sensitivity to the rapid paralytic and lethal actions of DDT and pyrethroid insecticides (Soderlund and Bloomquist 1990) . Because these insecticides are known to modify neuronal excitability by altering the inactivation kinetics of voltage-sensitive sodium channels (Soderlund and Bloomquist 1989; Bloomquist 1993), efforts to identify the molecular basis of kdr resistance have focused on the pharmacology and structure of this target. Recently, tight genetic linkage between the kdr trait and a restriction fragment length polymorphism located within a segment of the house fly homolog of the para gene of Drosophila melanogaster was demonstrated (Knipple et al . 1994). Similar linkage studies have also documented tight linkage of the super-kdr resistance trait of the house fly (Williamson et al . 1993) to molecular markers lying within the para-homologous voltage-sensitive sodium channel gene . Elucidation of the structure of the house fly sodium channel gene will enable the screening of potential insecticidal agents which act upon the sodium channel. A need continues to exist, therefore, for the determination of the primary structure of the house fly sodium channel, i.e. the nucleotide and amino acid sequences of the channel . SUMMARY OF INVENTION To this end, the subject invention provides the 6318 nucleotide coding sequence (SEQ ID NO:l) of the voltage-sensitive sodium channel gene from insecticide- susceptible (NAIDM strain) house flies (Musca domestica) , determined by automated direct DNA sequencing of PCR fragments obtained by amplification on first strand cDNA from adult heads. The deduced 2105-residue amino acid sequence (SEQ ID NO: 3) exhibits overall structure and organization typical of sodium channel alpha subunit genes and is 90.0% identical to that of the D. melanogaster para gene product . There is no evidence for the existence of multiple splice variants among voltage-sensitive sodium channel cDNAs obtained from adult house fly head preparations. Comparison of the coding sequence of the voltage-sensitive sodium channel gene of the kdr insecticide-resistant house fly strain (538ge strain) to that of the NAIDM strain reveals 12 amino acid differences in the 538ge strain. The amino acid sequence (SEQ ID NO:4) of the Kdr strain is only 2104 residues in length, as a result of five (5) amino acid substitutions, four (4) amino acid deletions, and three (3) amino acid insertions as compared to the 2105-residue amino acid sequence (SEQ ID NO: 3) of the NAIDM strain. The nucleotide sequence (SEQ ID NO: 2) of the Kdr strain is therefore 6315 nucleotides in length, which is three nucleotides shorter than the nucleotide sequence (SEQ ID N0:1) of the NAIDM strain. More particularly, the subject invention provides an isolated nucleic acid molecule encoding a voltage-sensitive sodium channel of Musca domestica, wherein the voltage-sensitive sodium channel is capable of conferring sensitivity or resistance to an insecticide in Musca domestica . In one embodiment, the nucleic acid molecule confers insecticide susceptibility to the house fly, and in another embodiment the nucleic acid molecule confers insecticide resistance to the house fly. The nucleic acid molecule conferring insecticide resistance is preferably a mutated form of the nucleic acid molecule encoding the insecticide susceptible channel . The invention also provides an antisense nucleic acid molecule complementary to mRNA encoding the voltage-sensitive sodium channel of Musca domestica . The isolated nucleic acid molecules of the invention can be inserted into suitable expression vectors and/or host cells. Expression of the nucleic acid molecules encoding the sodium channels results in production of functional sodium channels in a host cell. Expression of the antisense nucleic acid molecules or fragments thereof in a host cell results in decreased expression of the functional sodium channels. The invention further provides a ribozyme having a recognition sequence complementary to a portion of mRNA encoding a voltage-sensitive sodium channel of Musca domestica . The ribozyme can be introduced into a cell to also achieve decreased expression of sodium channels in the cell. The invention further provides a method of screening a chemical agent for the ability of the chemical agent to modify sodium channel function, and a method of obtaining DNA encoding a voltage-sensitive sodium channel of Musca domestica . Further provided is an isolated nucleic acid molecule encoding a voltage-sensitive sodium channel of an insect, wherein the nucleic acid molecule encodes a first amino acid sequence having at least 95% amino acid identity to a second amino acid sequence. The second amino acid sequence is, in two preferred embodiments, SEQ ID NO: 3 or SEQ ID NO : 4. The invention also provides an isolated voltage-sensitive sodium channel of Musca domestica, and antibodies or antibody fragments specific for the sodium channel . The antibodies or antibody fragments can be used to detect the presence of the sodium channel in samples . Further provided is an isolated voltage- sensitive sodium channel of Musca domestica, wherein the voltage-sensitive sodium channel is comprised of a protein having a first amino acid sequence with at least 95% amino acid identity to a second amino acid sequence. In two preferred embodiments, the second amino acid sequence is SEQ ID NO: 3 or SEQ ID NO : 4. Also provided by the subject invention is a plasmid designated pPJIl and deposited with the ATCC under Accession No.97831, as well as a Kpnl/Aatll restriction fragment of about 3620 bp of the plasmid designated pPJIl. Further provided is a plasmid designated pPJI2 and deposited with the ATCC under Accession No. 97832, as well as an Aatll/Sphll restriction fragment of about 2700 bp of the plasmid designated pPJI2. When the above two restriction fragments are ligated together at their Aatll sites, the resulting nucleic acid molecule encodes a voltage-sensitive sodium channel which confers susceptibility to an insecticide in Musca domestica . This resulting nucleic acid molecule is also provided by the subject invention. BRIEF DESCRIPTION OF THE DRAWINGS These and other features and advantages of this invention will be evident from the following detailed description of preferred embodiments when read in conjunction with the accompanying drawings in which: Fig. 1 is a model of a voltage sensitive sodium channel from mammalian brain in the plasma membrane. The alpha and beta x subunits interact noncovalently; the alpha and beta 2 subunits are linked by disulfide bonds. The branched structures at the outer surface of the channel represent oligosaccharides; Fig. 2 is a diagram of the structural organization of the voltage-sensitive sodium channel coding sequence of Musca domestica (Vsscl) showing repeated homology domains I-IV and putative transmembrane helices (rectangles) . Shown below the structural organization are the relative length and location of the previously-described 309-nucleotide exon of Vsscl (Knipple et al . 1994) (exon) and seven overlapping PCR-amplified cDNA fragments (A-G) employed as templates for DNA sequencing; Fig. 3 shows the alignment of the predicted amino acid sequences of Vsscl mx (NAIDM) and Vsscl 538ge (538ge) with that of the a + b ' c ' d + e ' f ' h ' i + splice variant of the D. melanogaster para sequence (para) obtained using the DNASTAR computer program (Clustal method) . Residues that are identical to the NAIDM sequence in both 538ge and para are indicated as dashes (-) in the latter two sequences; gaps introduced to obtain optimal alignment are indicated as periods ( . ) . The locations of 24 putative helical transmembrane domains (e.g., IS1, IS2, etc.) and four putative pore-forming domains (e.g., IP, IIP) are marked by solid bars above the NAIDM sequence. Also marked above the NAIDM sequence are possible sites for N- - linked glycosylation (#) , cAMP-dependent protein- kinase phosphorylation (*) , and protein kinase C phosphorylation (•) ; and Fig. 4 is a diagram of the Vsscl gene product showing the locations of 12 amino acid differences identified in the Vsscl 528ge sequence, including 5 amino acid substitutions, 4 amino acid deletions, and 3 amino acid insertions in the Vsscl 53896 sequence (R) as compared to the Vsscl ΝAIDM sequence (S) . DETAILED DESCRIPTION The plasmids designated pPJIl and pPJI2 have each been deposited pursuant to, and in satisfaction of, the requirements of the Budapest Treaty on the International Recognition of the Deposit of Microorganisms for the Purposes of Patent Procedure, with the American Type Culture Collection (ATCC) , 12301 Parklawn Drive, Rockville, Maryland, 20852 under ATCC Accession No. 97831 (pPJIl) and ATCC Accession No. 97832 (pPJI2) . Both deposits were made on December , 1996. As used herein, the term "isolated" when used in conjunction with a nucleic acid molecule refers to: 1) a nucleic acid molecule which has been separated from an organism in a substantially purified form (i.e. substantially free of other substances originating from that organism) , or 2) a nucleic acid molecule having the same nucleotide sequence but not necessarily separated from the organism (i.e. synthesized nucleic acid molecules) . The term "isolated" when used in conjunction with a channel refers to a channel encoded by such an "isolated" nucleic acid molecule, generally expressed in a membrane, such as a plasma membrane within a cell or a synthetic lipid bilayer membrane. The expressed "isolated" channel has the pharmacological properties of a functional sodium channel. As further used herein, the terms "corresponding to" or "having" or "as shown in" when used in conjunction with a SEQ ID NO for a nucleotide sequence refer to a nucleotide sequence which is substantially the same nucleotide sequence, or derivatives or equivalents thereof (such as deletion and hybrid variants thereof, splice variants thereof, etc.). Nucleotide additions, deletions, and/or substitutions, such as those which do not affect the translation of the DNA molecule, are within the scope of a nucleotide sequence corresponding to or having or as shown in a particular nucleotide sequence (i.e. the amino acid sequence encoded thereby remains the same) . Such additions, deletions, and/or substitutions can be, for example, point mutations made according to methods known to those skilled in the art. It is also possible to substitute a nucleotide which alters the amino acid sequence encoded thereby, where the amino acid substituted is a conservative substitution or where amino acid homology is conserved. It is also possible to have minor nucleotide additions, deletions, and/or substitutions which do not alter the function of the resulting VSSC. Similarly, the term "corresponding to" or "having" or "as shown in" when used in conjunction with a SEQ ID NO for an amino acid sequence refers to an amino acid sequence which is substantially the same amino acid sequence or derivatives or equivalents thereof. Amino acid additions, deletions, and/or substitutions which do not negate the ability of the resulting protein to form a functional sodium channel are within the scope of an amino acid sequence corresponding to or having or as shown in a particular amino acid sequence. Such additions, deletions, and/or substitutions can be, for example, the result of point mutations in the DNA encoding the amino acid sequence, such point mutations made according to methods known to those skilled in the art. Substitutions may be conservative substitutions of amino acids. As used herein, two amino acid residues are conservative substitutions of one another where the two residues are of the same type. In this regard, for purposes of the present invention, proline, alanine, glycine, serine, and threonine, all of which are neutral, weakly hydrophobic residues, are of the same type. Glutamine, glutamic acid, asparagine, and aspartic acid, all of which are acidic, hydrophilic residues, are of the same type. Another type of residue is the basic, hydrophilic amino acid residues, which include histidine, lysine, and arginine . Leucine, isoleucine, valine, and methionine all of which are hydrophobic, aliphatic amino acid residues, form yet another type of residue. Yet another type of residue consists of phenylalanine, tyrosine, and tryptophan, all of which are hydrophobic, aromatic residues. Further descriptions of the concept of conservative substitutions are given by French and Robson 1983, Taylor 1986, and Bordo and Argos 1991. As further used herein, the term "corresponding to" or "having" or "as shown in" or "consisting of" when used in conjunction with a SEQ ID NO for a nucleotide or amino acid sequence is intended to cover linear or cyclic versions of the recited sequence (cyclic referring to entirely cyclic versions or versions in which only a portion of the molecule is cyclic, including, for example, a single amino acid cyclic upon itself) , and is intended to cover derivative or modified nucleotides or amino acids within the recited sequence. For example, those skilled in the art will readily understand that an adenine nucleotide could be replaced with a methyladenine, or a cytosine nucleotide could be replaced with a methylcytosine, if a methyl side chain is desirable. Nucleotide sequences having a given SEQ ID NO are intended to encompass nucleotide sequences containing these and like derivative or modified nucleotides, as well as cyclic variations. As a further example, those skilled in the art will readily understand that an asparagine residue could be replaced with an ethylasparagine if an ethyl side chain is desired, a lysine residue could be replaced with a hydroxylysine if an OH side chain is desired, or a valine residue could be replaced with a methylvaline if a methyl side chain is desired. Amino acid sequences having a given SEQ ID NO are intended to encompass amino acid sequences containing these and like derivative or modified amino acids, as well as cyclic variations. Cyclic, as used herein, also refers to cyclic versions of the derivative or modified nucleotides and amino acids . The function of the encoded sodium channel can be assayed according to methods known in the art, such as by voltage clamp analysis of the channel following the functional expression of the channel in oocytes of the frog Xenopus laevis (see Taglialatela et al . 1992 and Stuhmer 1992 for a general discussion of the voltage clamp analysis of receptors and ion channels expressed in Xenopus oocytes) . As used herein, "functional expression" refers to the synthesis and any necessary post- translational processing of a sodium channel molecule in a host cell so that the channel is inserted properly in the cell membrane and is capable of conducting sodium ions in response to an experimentally-imposed change in the cell membrane potential or upon exposure to appropriate pharmacological agents. As further used herein, "sensitivity" and "resistance" refer to the relative responses of genetically-defined insect populations to the paralytic or lethal actions of a test insecticide. For example, a dose of DDT [1, 1-bis- (4-chlorophenyl) -2 , 2 , 2-trichloroethane] of approximately 0.02 μg per adult fly will kill approximately 50% of the treated individuals of a susceptible (Cooper-S) house fly strain, whereas doses of approximately 0.5 μg per adult fly are required to kill approximately 50% of the treated individuals of a resistant (538ge) house fly strain (Sawicki 1978) . The absolute doses that define susceptibility and resistance vary with the insect species and genetically defined populations examined, the test insecticide employed, and the method of exposure. In general, an insect strain or population is considered "resistant" if it exhibits tolerance to a test insecticide (assessed as the dose required to poison 50% of a treated population or group) that is at least 10 times greater than the tolerance of an appropriate reference, or "susceptible" population. Test insecticides include not only DDT but also analogs of DDT (e.g., methoxychlor, perthane) and pyrethroid insecticides (e.g., deltamethrin, fenvalerate, resmethrin, permethrin) . As also used herein, insects include Musca domestica (the house fly) , the fruit or vinegar fly (Drosophila melanogaster) , and various other insect species of agricultural, medical or veterinary importance, such as Heliothis virescens (the tobacco budworm) , Leptinotarsa decemlineata (the Colorado potato beetle) , Blattella germanica (the German cockroach) , and Aedes aegypti (the yellow fever mosquito) . The subject invention provides an isolated nucleic acid molecule encoding a voltage-sensitive sodium channel (VSSC) of Musca domestica, wherein the VSSC is capable of conferring sensitivity or resistance to an insecticide in Musca domestica . The nucleic acid molecule can be deoxyribonucleic acid (DNA) or ribonucleic acid (RNA, including messenger RNA or mRNA) , genomic or recombinant, biologically isolated or synthetic. The DNA molecule can be a cDNA molecule, which. is a DNA copy of a messenger RNA (mRNA) encoding, the VSSC. In one embodiment, the VSSC confers insecticide susceptibility to Musca domestica . An example of such an insecticide susceptible VSSC is the channel encoded by the nucleotide sequence as shown in SEQ ID N0:1. SEQ ID NO : 1 is the DNA sequence of one allele of the VSSC of Musca domestica . The amino acid sequence encoded by this allele is shown in SEQ ID NO: 3. In another embodiment, the VSSC confers insecticide resistance to Musca domestica . An example of such an insecticide resistant VSSC is the channel encoded by the nucleotide sequence as shown in SEQ ID NO : 2. SEQ ID NO: 2 is the DNA sequence of another allele of the VSSC of Musca domestica characteristic of the kdr insecticide resistant strain. The amino acid sequence encoded by this mutant allele is shown in SEQ ID NO:4. The insecticide resistant allele preferably has the nucleotide sequence of a second nucleic acid molecule with one or more mutations therein, wherein the second nucleic acid molecule encodes an insecticide sensitive VSSC and wherein one or more mutations in the second nucleic acid molecule render the resulting VSSC resistant to an insecticide (hence the term "mutant" allele) . In one embodiment, the mutant allele (having amino acid SEQ ID NO: 4) has the amino acid sequence encoded by the susceptibility allele (amino acid SEQ ID NO: 3) with amino acid differences as follows: a substitution of phenylalanine for leucine at amino acid residue 1014 of SEQ ID NO:3; a substitution of isoleucine for methionine at amino acid residue 1140 of SEQ ID NO: 3; a substitution of aspartic acid for glycine at amino acid residue 2023 of SEQ ID NO:3; a deletion of amino acid residues 2031-2034 of SEQ ID N0:3 (glycine-alanine-threonine-alanine) ; a substitution of threonine for serine at amino acid residue 2042 of SEQ ID NO: 3; a substitution of alanine for valine- at amino acid residue 2054 of SEQ ID NO: 3; and an insertion of three amino acid residues (asparagine- glycine-glycine) after amino acid residue 2055 of SEQ ID NO: 3 (between amino acid residues 2055 and 2056 of SEQ ID NO: 3) . One or more of these amino acid differences can be included in an insecticide resistant VSSC. Other suitable sites for mutations can be identified by conventional, molecular genetic approaches, such as the identification of amino acid sequence substitutions/insertions/deletions in the VSSC sequences of other insecticide-resistant house fly strains. The invention also provides an antisense nucleic acid molecule that is complementary to the mRNA encoding the VSSC, or a fragment thereof. Antisense nucleic acid molecules can be RNA or single-stranded DNA. Antisense molecules can be complementary to the entire DNA molecule encoding the VSSC, i.e. of the same nucleotide length as the entire molecule. It may be desirable, however, to work with a shorter molecule. In this instance, fragments of the entire antisense molecule can be used. Suitable fragments are capable of hybridizing to the mRNA encoding the entire molecule, and preferably consist of at least twenty nucleotides. These antisense molecules and fragments thereof can be used to reduce steady state levels of a VSSC gene product of Musca domestica, by introducing into cells an RNA or single- stranded DNA molecule that is complementary to the mRNA of the VSSC (i.e. by introducing an antisense molecule) . The antisense molecule can base-pair with the mRNA of the VSSC, preventing translation of the mRNA into protein. Thus, an antisense molecule to the VSSC of Musca domestica can prevent translation of mRNA encoding the VSSC into a functional sodium channel protein. More particularly, an antisense molecule complementary to mRNA encoding a VSSC of Musca domestica, or a fragment thereof, can be used to decrease expression of a functional VSSC of Musca domestica . A cell with a first level of expression of a functional VSSC of Musca domestica is first selected, and then the antisense molecule (or fragment thereof) is introduced into the cell. The antisense molecule (or fragment thereof) blocks expression of functional VSSCs of Musca domestica, resulting in a second level of expression of a functional VSSC of Musca domestica in the cell. The second level is less than the initial first level. Antisense molecules can be introduced into cells by any suitable means. Suitable cells include Xenopus oocytes which are useful host cells for studying the expression of the encoded sodium channel, and various insect cells, including but not limited to the insect cell lines Drosophila Schneider (Johansen et al . 1989), Drosophila K c (Sang 1981), Sf9 (Smith et al . 1983), and High Five ® (see U.S. Patent No. 5,300,435) . In one embodiment, the antisense RNA molecule is injected directly into the cellular cytoplasm, where the RNA interferes with translation. A vector may also be used for introduction of the antisense molecule into a cell. Such vectors include various plasmid and viral vectors . For a general discussion of antisense molecules and their use, see Han et al . 1991 and Rossi 1995. The invention further provides a special category of antisense RNA molecules, known as ribozymes, having recognition sequences complementary to specific regions of the mRNA encoding the VSSC of Musca domestica . Ribozymes not only complex with target sequences via complementary antisense sequences but also catalyze the hydrolysis, or cleavage, of the template mRNA molecule. Examples, which are not intended to be limiting, of suitable regions of the mRNA template to be targeted by ribozymes are any of the regions encoding the 24 putative transmembrane domains of the VSSC of Musca domestica . Expression of a ribozyme in a cell can inhibit gene expression (such as the expression of a VSSC of Musca domestica) . More particularly, a ribozyme having a recognition sequence complementary to a region of a mRNA encoding a VSSC of Musca domestica can be used to decrease expression of a functional VSSC of Musca domestica . A cell with a first level of expression of a functional VSSC of Musca domestica is first selected, and then the ribozyme is introduced into the cell. The ribozyme in the cell decreases expression of a functional VSSC of Musca domestica in the cell, because mRNA encoding the VSSC is cleaved and cannot be translated. Ribozymes can be introduced into cells by any suitable means. Suitable cells include Xenopus oocytes which are useful host cells for studying the expression of the encoded sodium channel, and various insect cells, including but not limited to the insect cell lines Drosophila Schneider, Drosophila K c , Sf9, and High Five ® . In one embodiment, the ribozyme is injected directly into the cellular cytoplasm, where the ribozyme cleaves the mRNA and thereby interferes with translation. A vector may be used for introduction of the ribozyme into a cell . Such vectors include various plasmid and viral vectors (note that the DNA encoding the ribozyme does not need to be "incorporated" into the genome of the host cell; it could be expressed in a host cell infected by a viral vector, with the vector expressing the ribozyme, for instance) . For a general discussion of ribozymes and their use, see Sarver et al . 1990, Chrisey et al . 1991, Rossi et al . 1992, and Christoffersen et al . 1995. The nucleic acid molecules of the subject invention can be expressed in suitable host cells using conventional techniques. Any suitable host and/or vector system can be used to express the VSSCs. These include, but are not limited to, eukaryotic hosts such as mammalian cells (i.e., Hela cells, Cv-1 cells, COS cells), Xenopus oocytes, and insect cells (i.e. insect cell lines such as Drosophila Schneider, Drosophila K c , Sf9, and High Five ® ) . Techniques for introducing the nucleic acid molecules into the host cells may involve the use of expression vectors which comprise the nucleic acid molecules. These expression vectors (such as plasmids and viruses; viruses including bacteriophage) can then be used to introduce the nucleic acid molecules into suitable host cells. For example, sodium channel expression is often studied in Xenopus oocytes . DNA encoding the VSSC can be injected into the oocyte nucleus or transformed into the oocyte using a suitable vector, or mRNA encoding the VSSC can be injected directly into the oocyte, in order to obtain expression of a functional VSSC in the oocyte. It may be beneficial when expressing the sodium channels of the subject invention in Xenopus oocytes to coexpress a nucleic acid molecule encoding a tipE protein (Feng et al . 1995) . Tip E has been found to be necessary to obtain expression of some sodium channels in Xenopus oocytes (Feng et al . 1995) . Various methods are known in the art for introducing nucleic acid molecules into host cells . One method is microinjection, in which DNA is injected directly into the nucleus of cells through fine glass needles (or RNA is injected directly into the cytoplasm of cells) . Alternatively, DNA can be incubated with an inert carbohydrate polymer (dextran) to which a positively charged chemical group (DEAE, for diethylaminoethyl) has been coupled. The DNA sticks to the DEAE-dextran via its negatively charged phosphate groups. These large DNA- containing particles stick in turn to the surfaces of cells, which are thought to take them in by a process known as endocytosis. Some of the DNA evades destruction in the cytoplasm of the cell and escapes to the nucleus, where it can be transcribed into RNA like any other gene in the cell. In another method, cells efficiently take in DNA in the form of a precipitate with calcium phosphate. In electroporation, cells are placed in a solution containing DNA and subjected to a brief electrical pulse that causes holes to open transiently in their membranes. DNA enters through the holes directly into the cytoplasm, bypassing the endocytotic vesicles through which they pass in the DEAE-dextran and calcium phosphate procedures (passage through these vesicles may sometimes destroy or damage DNA) . DNA can also be incorporated into artificial lipid vesicles, liposomes, which fuse with the cell membrane, delivering their contents directly into the cytoplasm. In an even more direct approach, used primarily with plant cells and tissues, DNA is absorbed to the surface of tungsten microprojectiles and fired into cells with a device resembling a shotgun. Several of these methods, microinjection, electroporation, and liposome fusion, have been adapted to introduce proteins into cells. For review, see Mannino and Gould-Fogerite 1988, Shigekawa and Dower 1988, Capecchi 1980, and Klein et al . 1987. Further methods for introducing nucleic acid molecules into cells involve the use of viral vectors . Since viral growth depends on the ability to get the viral genome into cells, viruses have devised clever and efficient methods for doing it. One such virus widely used for protein production is an insect virus, baculovirus. Baculovirus attracted the attention of researchers because during infection, it produces one of its structural proteins (the coat protein) to spectacular levels. If a foreign gene were to be substituted for this viral gene, it too ought to be produced at high level. Baculovirus, like vaccinia, is very large, and therefore foreign genes must be placed in the viral genome by recombination. To express a foreign gene in baculovirus, the gene of interest is cloned in place of the viral coat protein gene in a plasmid carrying a small portion of the viral genome. The recombinant plasmid is cotransfected into insect cells with wild-type baculovirus DNA. At a low frequency, the plasmid and viral DNAs recombine through homologous sequences, resulting in the insertion of the foreign gene into the viral genome. Virus plaques develop, and the plaques containing recombinant virus look different because they lack the coat protein. The plaques with recombinant virus are picked and expanded. This virus stock is then used to infect a fresh culture of insect cells, resulting in high expression of the foreign protein. For a review of baculovirus vectors, see Miller (1989) . Various viral vectors have also been used to transform mammalian cells, such as bacteriophage, vaccinia virus, adenovirus, and retrovirus. As indicated, some of these methods of transforming a cell require the use of an intermediate plasmid vector. U.S. Patent No. 4,237,224 to Cohen and Boyer describes the production of expression systems in the form of recombinant plasmids using restriction enzyme cleavage and ligation with DNA ligase. These recombinant plasmids are then introduced by means of transformation and replicated in unicellular cultures including procaryotic organisms and eucaryotic cells grown in tissue culture. The DNA sequences are cloned into the plasmid vector using standard cloning procedures known in the art, as described by Sambrook et al . (1989) . Host cells into which the nucleic acid encoding the VSSC has been introduced can be used to produce (i.e. to functionally express) the voltage-sensitive sodium channel . Having identified the nucleic acid molecules encoding VSSCs and methods for expressing functional channels encoded thereby, the invention further provides a method of screening a chemical agent for the ability of the chemical agent to modify sodium channel function. The method comprises introducing a nucleic acid molecule encoding the VSSC into a host cell, and expressing the VSSC encoded by the molecule in the host cell. The expression results in the functional expression of a VSSC in the membrane of the host cell. The cell is then exposed to a chemical agent and evaluated to determine if the chemical agent modifies the function of the VSSC. From this evaluation, chemical agents effective in altering the function of the sodium channel can be found. Such agents may be, for example, tetrodotoxin, veratridine, and scorpion venom toxins. Additional agents can be found in Soderlund and Knipple 1994. Cells transformed to include the VSSC according to the subject invention can be exposed to various potential insecticides and pesticides and evaluated for their susceptibility to the agents to develop and identify insect control agents that will not cause adverse effects to vertebrate species. Exemplary methods of screening are described in Eldefrawi et al . 1987 and Rauh et al . 1990. The evaluation of the function of the sodium channel can be by any means known in the art . In one embodiment , the evaluation comprises monitoring sodium transport through the VSSC. Sodium transport can be monitored by pre- incubating cells in a medium containing one or more chemical agents, adding a medium containing radiosodium ( 22 Na + ) , incubating the cells further in this medium, and isolating cells by filtration. Sodium transport is detected by the measurement of 22 Na + within the cells by liquid scintillation counting or other radiometric techniques (Bloomquist and Soderlund 1988) . Alternatively, [ 14 C] guanidinium ion can be employed as the radiotracer in the place of sodium using the same procedure (Jacques et al . 1978). In another embodiment, the function of the VSSC can be evaluated by pre- incubating cells to equilibrium with a sodium-selective fluorescent chelating agent (e.g., SBFI [sodium-binding benzofuran isophthalate] ) , washing the cells, exposing the cells to a test agent, and monitoring the increase in intracellular sodium by measuring the fluorescence of the SBFI -sodium complex (Deri and Adam-Vizi 1993) . The nucleic acid molecules of the subject invention can be used either as probes or for the design of primers to obtain DNA encoding other VSSCs by either cloning and colony/plaque hybridization or amplification using the polymerase chain reaction (PCR) . Specific probes derived from SEQ ID NOs 1 or 2 can be employed to identify colonies or plaques containing cloned DNA encoding a member of the VSSC family using known methods (see Sambrook et al . 1989) . One skilled in the art will recognize that by employing such probes under high stringency conditions (for example, hybridization at 42 °C with 5X SSPC and 50% formamide, washing at 50-65°C with 0.5X SSPC) , sequences having regions which are greater than 90% identical to the probe can be obtained. Sequences with lower percent identity to the probe, which also encode VSSCs, can be obtained by lowering the stringency of hybridization and washing (for example, by reducing the hybridization and wash temperatures or reducing the amount of formamide employed) . More particularly, in one embodiment, the method comprises selection of a DNA molecule encoding a VSSC of an insect, or a fragment thereof, the DNA molecule having a nucleotide sequence selected from the group consisting of SEQ ID N0:1 and SEQ ID NO: 2, and designing an oligonucleotide probe for a VSSC based on SEQ- ID NO : 1 or SEQ ID NO: 2. A genomic or cDNA library of an insect is then probed with the oligonucleotide probe, and clones are obtained from the library that are recognized by the oligonucleotide probe so as to obtain DNA encoding another VSSC. Specific primers derived from SEQ ID NOs 1 or 2 can be used in PCR to amplify a DNA sequence encoding a member of the VSSC family using known methods (see Innis et al . 1990) . One skilled in the art will recognize that by employing such primers under high stringency conditions (for example, annealing at 50-60°C, depending on the length and specific nucleotide content of the primers employed) , sequences having regions greater than 75% identical to the primers will be amplified. More particularly, in a further embodiment the method comprises selection of a DNA molecule encoding a VSSC of an insect, or a fragment thereof, the DNA molecule having a nucleotide sequence selected from the group consisting of SEQ ID NO:l and SEQ ID NO: 2, designing degenerate oligonucleotide primers based on regions of SEQ ID NO: 1 or SEQ ID NO: 2, and employing such primers in the polymerase chain reaction using as a template a DNA sample to be screened for the presence of VSSC-encoding sequences. The resulting PCR products can be isolated and sequenced to identify DNA fragments that encode polypeptide sequences corresponding to the targeted region of a VSSC. Various modifications of the nucleic acid and amino acid sequences disclosed herein are covered by the subject invention. These varied sequences still encode a functional VSSC. The invention thus further provides an isolated nucleic acid molecule encoding a VSSC of an insect, the nucleic acid molecule encoding a first amino acid sequence having at least 95% amino acid identity to a second amino acid sequence, the second amino acid sequence being as shown in SEQ ID NO: 3. The resulting encoded VSSC is susceptible to an insecticide. The invention also provides an isolated nucleic acid molecule encoding a VSSC of an insect, the nucleic acid molecule encoding a first amino acid sequence having at least 95% amino acid identity to a second amino acid sequence, the second amino acid sequence being as shown in SEQ ID NO:4. The resulting VSSC is resistant to an insecticide. The invention further provides isolated voltage-sensitive sodium channels of Musca domestica, wherein the VSSC is capable of conferring sensitivity or resistance to an insecticide in Musca domestica . In one embodiment, the VSSC confers susceptibility to an insecticide in Musca domestica, such as the VSSC encoded by the nucleotide sequence as shown in SEQ ID NO : 1 (which encodes an amino acid sequence as shown in SEQ ID NO: 3) . In a further embodiment, the VSSC confers resistance to an insecticide in Musca domestica, such as the VSSC encoded by the nucleotide sequence as shown in SEQ ID NO : 3 (which encodes an amino acid sequence as shown in SEQ ID NO: 4) . Preferably, the insecticide resistant VSSC is encoded by a nucleic acid molecule having the nucleotide sequence of a second nucleic acid molecule with one or more mutations therein, wherein the second nucleic acid molecule encodes an insecticide sensitive VSSC, and wherein the one or more mutations in the second nucleic acid molecule render the resulting voltage-sensitive sodium channel resistant to an insecticide. For example, the nucleotide sequence of the second nucleic acid molecule may encode amino acid SEQ ID NO: 3, and the insecticide resistant VSSC may have that amino acid sequence with one or more differences therein as follows: a substitution of phenylalanine for leucine at amino acid residue 1014 of SEQ ID NO: 3; a substitution of isoleucine for methionine at amino acid residue 1140 of SEQ ID NO: 3; a substitution of aspartic acid for-glycine at amino acid residue 2023 of SEQ ID NO: 3; a deletion of amino acid residues 2031-2034 of SEQ ID NO: 3 (glycine- alanine-threonine-alanine) ; a substitution of threonine for serine at amino acid residue 2042 of SEQ ID NO: 3; a substitution of alanine for valine at amino acid residue 2054 of SEQ ID NO : 3 ; and an insertion of three amino acid residues (asparagine-glycine-glycine) after amino acid residue 2055 of SEQ ID NO: 3 (between amino acid residues 2055 and 2056 of SEQ ID NO:3) . A variety of methodologies known in the art can be utilized to obtain an isolated VSSC according to the subject invention. In one method, the channel protein is purified from tissues or cells which naturally produce the channel protein. One skilled in the art can readily follow known methods for isolating proteins in order to obtain a member of the VSSC protein family, free of natural contaminants. These include, but are not limited to, immunochromatography, HPLC, size-exclusion chromatography, ion-exchange chromatography, and immunoaffinity chromatography. In another embodiment, a member of the VSSC family can be purified from cells which have been altered to express the channel protein. As used herein, a cell is said to be "altered to express the channel protein" when the cell, through genetic manipulation, is made to produce the channel protein which it normally does not produce or which the cell normally produces at low levels. One skilled in the art can readily adapt procedures for introducing and expressing either genomic, cDNA or synthetic sequences into either eukaryotic or prokaryotic cells in order to generate a cell which produces a member of the VSSC family utilizing the sequences disclosed herein. A VSSC as defined herein includes molecules encoding VSSCs encoded by an amino acid sequence-having at least 95% amino acid identity to SEQ ID NO: 3 or to SEQ ID NO : 4. Antibodies can be raised to the voltage- sensitive sodium channel. Antibodies of the subject invention include polyclonal antibodies and monoclonal antibodies capable of binding to the channel protein, as well as fragments of these antibodies, and humanized forms. Humanized forms of the antibodies of the subject invention may be generated using one of the procedures known in the art such as chimerization. Fragments of the antibodies of the present invention include, but are not limited to, the Fab, the Fab2, and the Fd fragments. The invention also provides hybridomas which are capable of producing the above-described antibodies. A hybridoma is an immortalized cell line which is capable of secreting a specific monoclonal antibody. In general, techniques for preparing polyclonal and monoclonal antibodies as well as hybridomas capable of producing the desired antibody are well known in the art (see Campbell 1984 and St. Groth et al . 1980) . Any animal (mouse, rabbit, etc.) which is known to produce antibodies can be immunized with the antigenic channel protein (or an antigenic fragment thereof) . Methods for immunization are well known in the art. Such methods include subcutaneous or intraperitoneal injection of the protein. One skilled in the art will recognize that the amount of the channel protein used for immunization will vary based on the animal which is immunized, the antigenicity of the protein, and the site of injection. The protein which is used as an immunogen may be modified or administered in an adjuvant in order to increase the protein's antigenicity. Methods of increasing the antigenicity of a protein are well known in the art and include, but are not limited to, coupling the antigen with a heterologous protein (such as a globulin or beta-galactosidase) or through the inclusion of an adjuvant during immunization. For monoclonal antibodies, spleen cells from the immunized animals are removed, fused with myeloma cells, such as SP2/0-Ag 15 myeloma cells, and allowed to become monoclonal antibody producing hybridoma cells. Any one of a number of methods well known in the art can be used to identify the hybridoma cell which produces an antibody with the desired characteristics. These include screening the hybridomas with an ELISA assay, western blot analysis, or radioimmunoassay (Lutz et al. 1988) . Hybridomas secreting the desired antibodies are cloned and the class and subclass are determined using procedures known in the art (Campbell 1984) . For polyclonal antibodies, antibody containing antisera is isolated from the immunized animal and is screened for the presence of antibodies with the desired specificity using one of the above-described procedures. The present invention further provides the above-described antibodies in detectably labeled form. Antibodies can be detectably labeled through the use of radioisotopes, affinity labels (such as biotin, avidin, etc.), enzymatic labels (such as horseradish peroxidase, alkaline phosphatase, etc.), fluorescent labels (such as FITC or rhodamine, etc.), paramagnetic atoms, etc. Procedures for accomplishing such labeling are well known in the art, for example see Sternberger et al . 1970, Bayer et al. 1979, Engval et al . 1972, and Goding 1976. The labeled antibodies or fragments thereof of the present invention can be used for in vitro, in vivo, and in situ assays to identify cells or tissues which express a VSSC, to identify samples containing the VSSC proteins, or to detect the presence of a VSSC in a sample*. More particularly, the antibodies or fragments thereof can thus be used to detect the presence of a VSSC in a sample, by contacting the sample with the antibody or fragment thereof. The antibody or fragment thereof binds to any VSSC present in the sample, forming a complex therewith. The complex can then be detected, thereby detecting the presence of the VSSC in the sample. Fragments of the nucleic acid molecules encoding a VSSC are also provided, and are best defined in the context of amino acid sequence relationships among members of the VSSC sequence family and information on the function of specific VSSC domains. For example the amino acid sequence encoded by nucleotides 4648-4803 of SEQ ID NOs 1 or 2 encodes an amino acid sequence that is highly conserved among VSSC family members and is identified as the structural component forming the "inactivation gate" of sodium channels. Antibodies prepared to the polypeptide encoded by this fragment would therefore be expected to be of use as reagents capable of detecting many members of the VSSC family. Such antibodies, if introduced into cells that express VSSCs, would also be expected to modify the normal function of the VSSCs expressed in those cells. In contrast, the amino acid sequence encoded by nucleotides 3079-3852 of SEQ ID NOs 1 or 2 encodes an amino acid sequence that is less well conserved between the VSSCs of the insects Musca domestica and Drosophila melanogaster. Antibodies prepared to the polypeptide encoded by this fragment would therefore be expected to recognize selectively the VSSC from which the fragment was derived. Also provided by the subject invention is a plasmid designated pPJIl and deposited with the ATCC under Accession No.97831, as well as a Kpnl/Aatll restriction fragment of about 3620 bp of the plasmid designated pPJIl. Further provided is a plasmid designated pPJI2 and deposited with the ATCC under Accession No. 97832, as well as an Aatll/Sphll restriction fragment of about 2700 bp of the plasmid designated pPJI2. When the above two restriction fragments are ligated together at their Aatll sites, the resulting nucleic acid molecule encodes a voltage-sensitive sodium channel which confers susceptibility to an insecticide in Musca domestica . This resulting nucleic acid molecule is also provided by the subject invention. MATERIALS AND METHODS Heads of newly-emerged adult house flies (NAIDM or 538ge strain) (Knipple et al . 1994) were ground to a fine powder under liquid N 2 and extracted with acid guanidinium isothiocyanate/phenol/chloroform to obtain total RNA (Chomczynski and Sacchi 1987) , which was fractionated on oligo (dT) -paramagnetic beads (PolyATtract mRNA isolation system; Promega, Madison, WI) to obtain poly(A + ) RNA. Pools of first strand cDNA were synthesized using either random hexamers (Harvey and Darlison 1991) or oligo (dT) adapted for the 3 '-RACE procedure (Frohman and Martin 1989) . These cDNA pools were employed as templates in the polymerase chain reaction (PCR) (Saiki et al . 1988) to amplify overlapping cDNA segments spanning the entire Vsscl coding sequence. Mixed-sequence oligonucleotide primers employed for these amplifications comprised all possible sequence combinations encoding short (i.e., 6-8 residues) regions of amino acid conservation between the para gene of D. melanogaster and rat brain sodium channel I (Loughney et al . 1989; Knipple et al . 1991). In a few cases, mixed-sequence primers were based solely on the D. melanogaster sequence. Defined-sequence primers were derived either from the previously described 309- nucleotide exon of the house fly Vsscl gene (Knipple et al . 1994) or from internal sequences of house fly cDNA fragments obtained by amplification with mixed-sequence primers. All primers were synthesized using an Applied Biosystems 392 instrument, deprotected using procedures provided by Applied Biosystems, desalted, and used without further purification. The sequences and designations of these primers are given in Table I . The methods and reagents employed in PCR amplifications are described elsewhere (Knipple et al . 1991; Henderson et al . 1994; Knipple et al . 1994); specific amplification conditions for each cDNA fragment were optimized by varying the annealing temperatures and extension times of the reaction. Following amplification, PCR products were separated from excess primers either by filtration of the reaction mixture through a Centricon-100 concentrator (Amicon, Beverly, MA) or by preparative electrophoresis on agarose gels, excision of the desired product, and extraction from the gel matrix (QIAquick spin column; Qiagen, Chatsworth, CA) prior to use as templates for DNA sequencing. The DNA sequences of amplified cDNA fragments were determined by automated sequencing with an Applied Biosystems 373 instrument using fluorescently-labeled dideoxynucleotides and Taq DNA polymerase (PCR/Sequencing Kit; Applied Biosystems, Foster City, CA) in a modification of the dideoxynucleotide chain-termination method (Sanger et al . 1977). Sequencing of each amplification product was initiated by using the amplification primers to sequence inward from the termini, and additional primers were synthesized as needed to obtain the complete sequence of each strand. Mixed- sequence amplification primers were employed for sequencing at concentrations 10-fold higher than that used for defined-sequence primers. All sequence ambiguities and apparent polymorphisms were resolved by performing additional multiple sequencing reactions. The full-length Vsscl coding sequences from the NAIDM and 538ge strains were compiled from 239 and 209 individual sequencing reactions, respectively, and were edited using the SeqEd software program (Applied Biosystems) . Complete house fly Vsscl sequences were analyzed and compared with published sodium channel sequences using the DNASTAR software package (DNASTAR, Madison, WI) . EXAMPLE I SEQUENCING OF THE INSECTICIDE SENSITIVE VSSC OF HOUSE FLY As an expedient alternative to conventional iterative screenings of cDNA libraries, a sequencing strategy for the house fly Vsscl gene was based on the PCR amplification and direct automated sequencing of overlapping cDNA fragments (Fig. 2) . The point of entry for this strategy was the 309-nucleotide exon of the house fly Vsscl gene identified previously from sequencing of cloned genomic DNA (Knipple et al . 1994) . The use of defined-sequence primers from this region (Table I, Al or B2) in combination with mixed-sequence primers encoding conserved amino acid sequences in either region IIS3 (A2) or the extracellular N-terminal domain (Bl) gave cDΝA fragments A and B. A second point of entry was established in homology domain IV using a pair of mixed-sequence primers (Cl and C2) to obtain fragment C. A primer (D2) designed from the internal sequence of fragment C, together with a mixed-sequence primer (Dl) encoding a conserved amino acid motif in the short linker between homology domains III and IV, gave fragment D. A pair of defined-sequence primers (El, E2) based on internal sequences of fragments A and D gave the large fragment E, which spanned most of homology domain II and all of homology domain III. Fragment F, corresponding to the 5' end of the coding sequence, was obtained using a-defined- sequence primer (F2) derived from the internal sequence of fragment B and a mixed-sequence primer (Fl) derived from a segment of the D. melanogaster sequence upstream from the translation start site (Loughney et al . 1989). Similarly, fragment G, containing the 3' end of the coding sequence, was obtained using a defined-sequence primer (Gl) derived from the internal sequence of fragment C and a mixed- sequence primer (G2) derived from a segment of the D. melanogaster sequence downstream from the stop codon (Thackeray and Ganetzky 1994) . The complete coding sequence of the Vsscl N τOl allele of the house fly, comprising a single open reading frame of 6318 nucleotides (SEQ ID NO:l), was determined by automated DNA sequencing using cDNA fragments A - G as templates (Fig. 2) . This cDNA coded for a 2105-amino acid polypeptide (SEQ ID NO: 3) with a predicted molecular weight of 236,671 Daltons that exhibited all of the common structural landmarks found in sodium channel o; subunit genes (Catterall 1992; Kallen et al . 1993) (see Fig. 3), including four large internally homologous subdomains (I- IV) , each containing six hydrophobic putative transmembrane helices (S1-S6) and a conserved sequence element between domains S5 and S6 identified as an ion pore-forming domain. The deduced Vsscl Nhτm amino acid sequence also contained a conserved element in the S4 region of each homology domain, characterized by a repeated motif of positively-charged amino acids that are thought to form the voltage-sensing element of the channel , and a short segment of conserved sequence between homology domains III and IV that has been identified as the channel inactivation gate (see Fig. 3) . The deduced Vsscl NAim protein contained 10 potential sites for N-linked glycosylation (Kornfeld and Kornfeld 1985) , 6 of which occur in putative extracellular regions. These regions of other sodium channel a subunit sequences are also known to contain potential glycosylation sites (Catterall 1992; Kallen et al . 1993) . Vertebrate sodium channels are known to undergo functional regulation as the result of phosphorylation by cAMP-dependent protein kinases at sites in the intracellular linker between homology domains I and II and by protein kinase C at a site in the intracellular linker between homology domains III and IV (Catterall 1992; Kallen et al . 1993). The deduced Vsscl miOM protein contained three potential cAMP-dependent protein kinase phosphorylation sites (Kemp and Pearson 1990) (Ser540, Ser557, and Ser628) in the cytoplasmic linker between homology domains I and II. The location of two of these (Ser540 and Ser557 of SEQ ID NO: 3) corresponded to the cluster of four sites found in this region of vertebrate brain sodium channels that are implicated in sodium channel regulation (Catterall 1992) . The deduced Vsscl NAτm protein also contained three additional potential phosphorylation sites (Serll67, Serl207, and Ser2097 of SEQ ID NO: 3) in other putative intracellular domains. The role of these phosphorylation sites in the regulation of insect sodium channels by cAMP-dependent protein kinase is not known. The deduced house fly voltage-sensitive sodium channel protein also contained two potential sites for protein kinase C phosphorylation (Serll91 and Serl582 of SEQ ID NO:3) (Kemp and Pearson 1990), the latter of which is the conserved site located within the inactivation gate sequence of the cytoplasmic linker between domains III and IV. Although the conservation of this site implicates a role for protein kinase C in the regulation of insect sodium channels, such an effect has not been demonstrated experimentally . The deduced Vsscl 1 ™ protein was 90.0% identical to the most similar variant of the para gene product of D. melanogaster (SEQ ID NO: 19) (Loughney et al . 1989; Thackeray and Ganetzky 1994) (Fig. 3) . The level of sequence identity was highest (≥95%) in the N-terminal intracellular domain, the linker between homology domains III and IV, and homology domain IV. The level of sequence identity was lowest (73%) in the intracellular C- erminal domain. Alignment of the Vsscl sequence with 12 other sodium channel α subunit sequences found in the GenBank database showed that the Vsscl and para gene products exhibited approximately the same degree of sequence similarity as homologous sodium channel α. subunit isoforms from different vertebrate species. These findings confirm and extend previous observations (Williamson et al . 1993; Knipple et al . 1994), based on fragmentary genomic DΝA and cDΝA sequences, of the high degree of sequence similarity between this house fly gene and the para gene of D. melanogaster and reinforce the conclusion that Vsscl is the homolog of para in the house fly. In D. melanogaster (Thackeray and Ganetzky 1994; O'Dowd et al . 1995) and Drosophila virilis (Thackeray and Ganetzky 1995) , multiple sodium channel α subunit variants, each under specific developmental regulation, are generated from the para gene by the alternative usage of 8 exons (designated a-f, h, and i) located in homology domain II and portions of the cytoplasmic linker regions on either side of this domain. Given the heterogeneity of sodium channel-encoding sequences found in these Dipteran species, it was surprising to detect only a single sequence variant among the pool of amplified house fly head cDΝA fragments. The Vsscl NAτm sequence contained segments identical to exon a and homologous (21 identical amino acids out of 24) to exon i of D. melanogaster. Recent studies suggest that both of these exons are required for the expression of high sodium current densities in embryonic D. melanogaster neurons (O'Dowd et al. 1995) . In the region encoded by either exon c or exon d, the house fly sequence differs from both D. melanogaster sequences but is slightly more similar to exon d (50 identical amino acids out of 55) than to exon c (49 identical amino acids out of 55) . The house fly sequence lacked segments homologous to D. melanogaster exons b, e, and f but contained a segment identical to exon h, which is a variable element found in some D. virilis sequences but not detected in D . melanogaster. The house fly Vsscl mιm sequence described is thus characterized as structurally homologous to the a * b ~ c ~ d * e ~ f ~ h + i + splice variant of D. melanogaster and D. virilis . The identification of this molecular form as the predominant sodium channel sequence variant in house fly heads was unexpected because it has not been detected among the arrays of splice variants detected in whole embryos or whole adults of either D. melanogaster or D. virilis. EXAMPLE II SEQUENCING OF THE INSECTICIDE RESISTANT VSSC OF HOUSE FLY The PCR amplification/ sequencing strategy summarized in Fig. 2 was also employed to determine the sequence of Vsscl cDNAs from heads of the 538ge house fly strain that carries the kdr trait. The nucleotide sequence of the VSSC of the 538ge house fly is shown in SEQ ID NO: 2, and the amino acid sequence is shown in SEQ ID NO:4. The amino acid sequence of 2104 residues (SEQ ID NO: 4) encoded by the Vsscl 53Bge cDNA contained 12 amino acid differences compared to that of the Vsscl NAIDM sequence (SEQ ID NO: 3) as follows: a substitution of phenylalanine for leucine at amino acid residue 1014 of SEQ ID NO: 3; a substitution of isoleucine for methionine at amino acid residue 1140 of SEQ ID NO: 3; a substitution of aspartic acid for glycine at amino acid residue 2023 of SEQ ID NO: 3; a deletion of amino acid residues 2031-2034 of SEQ ID N0:3 (glycine-alanine-threonine-alanine) ; a substitution of threonine for serine at amino acid residue 2042 of SEQ ID NO: 3; a substitution of alanine for valine at amino acid residue 2054 of SEQ ID NO: 3; and an insertion of three amino acid residues (asparagine- glycine-glycine) after amino acid residue 2055 of SEQ ID NO: 3 (between amino acid residues 2055 and 2056 of SEQ ID NO: 3) . A comparison of the Vsscl 5283e (SEQ ID NO:4) and Vssc2 NAIDM (SEQ ID NO: 3) amino acid sequences to the para sequence of the Canton-S strain of D. melanogaster (SEQ ID NO: 19) is shown in Fig. 3. The locations and amino acid sequence context of the differences are shown in Fig. 4. In Fig. 4, S refers to the NAIDM amino acid sequence (SEQ ID NO:3), and R refers to the kdr sequence (SEQ ID NO:4) . Dashes indicate that the Kdr sequence has the identical residue at that position as does the NAIDM sequence. The difference labeled 1 shows amino acids 1009-1019 of SEQ ID NO: 3, with the amino acid substitution at residue 1014 shown. The difference labeled 2 shows amino acids 1135- 1145 of SEQ ID NO : 3 , with the amino acid substitution at residue 1140 shown. The difference labeled 3 shows amino acids 2018-2028 of SEQ ID NO: 3, with the amino acid substitution at residue 2023 shown. The difference labeled 4 shows amino acids 2027-2038 of SEQ ID NO : 3 , with the deletion of residues 2031-2034 shown. The difference labeled 5 shows amino acids 2037-2047 of SEQ ID NO: 3, with the amino acid substitution at residue 2042 shown. The difference labeled 6 shows amino acids 2051-2059 of SEQ ID NO : 3 , with the amino acid substitution at residue 2054 shown and the insertion of three residues between 2055 and 2056 shown. Although preferred embodiments have been depicted and described in detail herein, it will be apparent to those skilled in the relevant art that various modifications, additions, substitutions and the like can be made without departing from the spirit of the invention and these are therefore considered to be within the scope of the invention as defined in the claims which follow. Table 1. Names and sequences of oligonucleotide primers used in the PCR amplification of partial Vsscl cDNAs . Name Sequence Al 5 -CGGTTGGGCTTTCCTGTC-3' SEQ ID NO : 5 A2 5 -GGGAATTCRAADATRTTCCANCCYTC-3' SEQ ID NO : 6 Bl 5 -CCCGARGAYATHGAYCYNTAYTA-3' SEQ ID NO : 7 B B22 5 5' -CGTATCGCCTCCTCCTCG-3' SEQ ID NO : 8 Cl 5 -GGGTCTAGATHTTYGCNATHTTYGGNATG'3' SEQ ID NO: 9 C2 5 -GGGGAATTCNGGRTCRAAYTGYTGCCA-3' SEQ ID NO: 10 Dl 5 ■ GGGTCTAGARGANCARAARAARTAYTA-3' SEQ ID NO: 11 D2 5 -TCATACTTTGGCCCAATGTC-3' SEQ ID NO: 12 E Ell 5 5' -CCCGAATTAGAGAAGGTGCTG-3' SEQ ID NO: 13 E2 5 -ACTATTGCTTGTGGTCGCCAC-3' SEQ ID NO: 14 Fl 5 -CATCNTTRGCNGCNTAGACNATGAC-3' SEQ ID NO: 15 F2 5 -GATTGAATGGATCGAGCAGCC-3' SEQ ID NO: 16 Gl 5 -CGTTTCTCCTTTCATATCTAG-3' SEQ ID NO: 17 G G22 5 5' -GGAGBGGBGGNCKBGGNCKNGCTCA-3' SEQ ID NO: 18 Designation of oligonucleotide mixtures: B=G+T+C; D=G+A+T; H=A+T+C; K=G+T; N=A+C+G+T; R=A+G; Y=C+T. LIST OF REFERENCES CITED Barchi, R.L., Probing the Molecular Architecture of the Voltage-Dependent Sodium Channel in "The Molecular Biology of Receptors, Pumps, and Channels: Pharmacological Targets," ASPET Meeting Abstracts; (Aug. 1988). Bayer, E.A., et al . , et Enzym 62:308 (1979). Bloomquist, J.R. In Reviews in Pesticide Toxicology (Edited by M. Roe and R.J. Kuhr) , pp. 181-226. Toxicology Communications, Raleigh, NC (1993) . Bloomquist, J.R. , and Soderlund, D.M. , Mol Pharmacol 33:543-550 (1988) . Bordo, D. and Argos, P., J Mol Biol 217:721-729 (1991). Campbell, A.M., "Monoclonal Antibody Technology: Laboratory Techniques in Biochemistry and Molecular Biology", Elsevier Science Publishers, Amsterdam, The Netherlands (1984) . Capecchi, M. , Cell 22:479-488 (1980). Catterall, W.A. et al . , Molec Pharmacol 20:533-542 (1981). Catterall, W.A., Ann Rev Biochem 55:953-985 (1986). Catterall, W.A. , Physiological Reviews 72 (4) : S14-S48 (1992) . Chomczynski, P. and Sacchi, N. , Anal Biochem 162:156-159 (1987) . Chrisey, L., et al . , Antisense Research and Development 1(1) :57-63 (1991) . Christoffersen, R.E. and Marr, J.J., Journal of Medicinal Chemistry 38 (12) :2023-2037 (1995). Deri, Z. and Adam-Vizi, V., J Neurochem 61:818-825 (1993). Eldefrawi et al . , FASEB J 1:262-271 (1987). Engval, E. et al . , Immunol 109:129 (1972). Feng, G. , et al . , Cell 82:1001-1011 (1995). Frelin, C. , et al . , Pflugers Arch 402:121-128 (1984). French, S. and Robson, B., J Molecular Evolu tion 19:171- 175 (1983) . Frohman, M.A. and Martin, G.R., Technique 1:165-170 (1989) . Goding, J.W. , J Immunol Meth 13:215 (1976). Han, L., et al . , Proc Natl Acad Sci USA 88:4313-4317 (1991) . Harvey, R.J. and Darlison, M.G. , Nucl Acids Res 19:4002 (1991) . Henderson, J.E., et al . , Insect Biochem. Mol Biol 24:363- 371 (1994) . Innis, et al . , PCR Protocols, Academic Press, San Diego, CA (1990) . Isom, et al., Science 256:839-842 (1992). Isom, et al., Neuron 12:1183-1194 (1994). Jacques, Y. , et al . , J Biol Chem 253 (20) : 7383-7392 (1978). Johansen, H. , et al . , Genes & Development 3:882-889 (1989) . Kallen, R.G. , et al . , Mol Neurobiol 7:383-428 (1993). Kemp, B.E. and Pearson, R.B., Trends Biochem Sci 15:342- 346 (1990) . Klein, T.M., et al . , Nature 327:70-73 (1987). Knipple, D.C., et al . , Proc Natl Acad Sci USA 91:2483-2487 (1994) . Knipple, D.C., et al . , Arch Insect Biochem Physiol 16:45- 53 (1991) . Kornfeld, R. and Kornfeld, S., Annu .Rev Biochem 54:931-664 (1985) . Loughney, K. , et al . , Cell 58:1143-1154 (1989). Lutz, et al., Exp Cell Res 175:109-124 (1988). Mannino, R.J. and Gould-Fogerite, S., BioTechniques 6:682- 690 (1988) . Miller, L.K., Bioessays 11:91-95 (1989). Moczydlowski, E., et al . , Proc Natl Acad Sci USA 83:5321- 5325 (1986) . Noda, M., et al . , Nature 312:121-127 (1984). Noda, M., et al . , Nature 320:188-192 (1986). O'Dowd, D.K., et al . , J Neurosci 15:4005-4012 (1995). Okamoto et al . , Proc Jpn Acad 63:284-288 (1987). Ramaswami and Tanouye, Proc Natl Acad Sci USA 86:2079-2082 (1989) . Rauh et al . , Trends in Pharmacol Sci 11:325-329 (1990). Rogart, R.B., Ann Netv York Acad Sci 479:402-430 (1986) . Rossi, J.J., Bri tish Medical Bulletin 51 (1) : 217-225 (1995) . Rossi, J.J., et al . , AIDS Research and Human Retroviruses 8 (2) :183-189 (1992) . Saiki, R.K., et al . , Science 239:487-491 (1988). Sambrook et al . Molecular Cloning: A Laboratory Manual, 2d Edition, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York (1989) . Sang, J.H., Adv Cell Cul ture 1:125-182 (1981). Sanger, F., et al . , Proc Natl Acad Sci USA 74 : 5463-5467 (1977) . Sarver, N. , et al . , Science 247:1222-1225 (1990). Sawicki, R.M. , Nature 275 (5679) :443-444 (1978). Shigekawa, K. and Dower, W.J., BioTechniques 6:742-751 (1988) . Smith, G.E., et al . , Mol Cell Biol 3:2156-2165 (1983). Soderlund, D.M. and Bloomquist, J.R. Annu Rev Entomol 34:77-96 (1989) . Soderlund, D.M. and Bloomquist, J.R., in Pesticide Resistance in Arthropods (Edited by R.T.Roush and B.E. Tabashnik) , pp. 58-96. Chapman and Hall, New York, NY (1990) . Soderlund, D.M., and Knipple, D.C., in Molecular Action of Insecticides on Ion Channels, eds. Clark, J.M. , American Chemical Society, Washington, D.C., pp. 97-108 (1994). St. Groth, et al., J Immunol Methods 35:1-21 (1980). Sternberger, L.A., et al . , J Histochem Cytochem 18:315 (1970) . Stuhmer, W., Methods in Enzymology 207:319-339 (1992). Suzuki et al . , Proc Natl Acad Sci USA 68:890-893 (1971). Taglialatela, M., et al . , Biophys J 61:78-82 (1992). Taylor, W.R., J Theor Biol 119:205-218 (1986). Thackeray, J.R. and Ganetzky, B., J Neurosci 14:2569-2578 (1994) . Thackeray, J.R. and Ganetzky, B., Genetics 141:203-214 (1995) . Williamson, M.S., et al . , Mol Gen Genet 240:17-22 (1993) SEQUENCE LISTING (1) GENERAL INFORMATION: (i) APPLICANT: Cornell Research Foundation, Inc-. (ii) TITLE OF INVENTION: INSECT SODIUM CHANNELS FROM INSECTICIDE-SUSCEPTIBLE AND INSECTICIDE-RESISTANT HOUSE FLIES (iii) NUMBER OF SEQUENCES: 19 (iv) CORRESPONDENCE ADDRESS: (A) ADDRESSEE: NIXON, HARGRAVE, DEVANS & DOYLE LLP (B) STREET: Clinton Square, P.O. Box 1051 (C) CITY: Rochester (D) STATE: New York (E) COUNTRY: USA (F) ZIP: 14603 (v) COMPUTER READABLE FORM: (A) MEDIUM TYPE: Floppy disk (B) COMPUTER: IBM PC compatible (C) OPERATING SYSTEM: PC-DOS/MS-DOS (D) SOFTWARE: PatentIn Release #1.0, Version #1.30 (vi) CURRENT APPLICATION DATA: (A) APPLICATION NUMBER: (B) FILING DATE: (C) CLASSIFICATION: (vii) PRIOR APPLICATION DATA: (A) APPLICATION NUMBER: US 08/772,512 (B) FILING DATE: 24-DEC-1996 (viii) ATTORNEY/AGENT INFORMATION: (A) NAME: Goldman, Michael L. (B) REGISTRATION NUMBER: 30,727 (C) REFERENCE/DOCKET NUMBER: 19603/602 (ix) TELECOMMUNICATION INFORMATION: (A) TELEPHONE: 716-263-1304 (B) TELEFAX: 716-263-1600 (2) INFORMATION FOR SEQ ID NO : 1 : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 6318 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS : single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA (xi) SEQUENCE DESCRIPTION: SEQ ID NO:l: ATGACAGAAG ATTCCGACTC GATATCTGAG GAAGAACGCA GTTTGTTCCG TCCCTTCACC 60 CGCGAATCAT TGTTACAAAT CGAACAACGT ATCGCTGAAC ATGAAAAACA AAAGGAGCTG 120 GAAAGAAAGA GAGCCGCCGA AGGAGAGCAG ATACGATATG ATGACGAGGA CGAAGATGAA 180 GGTCCACAGC CGGATCCCAC ACTTGAACAG GGTGTGCCTA TACCTGTTCG AATGCAGGGC 240 AGCTTCCCGC CGGAATTGGC CTCCACTCCT CTCGAGGATA TCGATCCCTT CTACAGTAAT 300 GTACTGACAT TTGTAGTAAT AAGTAAAGGA AAGGATATTT TTCGTTTTTC TGCCTCAAAA 360 GCAATGTGGC TGCTCGATCC ATTCAATCCG ATACGTCGTG TAGCCATTTA TATTTTAGTG 420 CATCCCTTGT TTTCGTTATT CATTATCACC ACTATTCTAA CTAATTGTAT TTTAATGATA 480 ATGCCGACAA CGCCCACGGT CGAATCCACA GAGGTGATAT TCACCGGAAT CTACACATTT 540 GAATCAGCTG TTAAAGTGAT GGCACGAGGT TTCATTTTAT GCCCGTTTAC GTATCTTAGA 600 GATGCATGGA ATTGGCTGGA CTTCGTAGTA ATAGCTTTAG CTTATGTGAC CATGGGCATA 660 GATTTAGGTA ATCTCGCAGC TTTGAGAACA TTTAGGGTAC TGCGAGCTCT GAAAACCGTA 720 GCCATTGTGC CAGGTCTAAA AACCATTGTC GGTGCTGTCA TTGAATCTGT AAAAAATCTA 780 CGCGATGTGA TAATTTTGAC AATGTTTTCC CTGTCGGTGT TCGCGCTGAT GGGCCTACAA 840 ATCTATATGG GTGTTCTAAC ACAAAAGTGC ATTAAACGAT TCCCCCTGGA CGGCAGTTGG 900 GGCAATCTGA CCGATGAAAA CTGGTTTCTA CACAATAGCA ACAGTTCCAA TTGGTTTACG 960 GAGAACGATG GCGAGTCATA TCCGGTGTGC GGGAATGTAT CCGGTGCGGG ACAATGCGGC 1020 GAGGATTACG TCTGCCTGCA GGGCTTCGGC CCCAATCCCA ACTACGACTA CACCAGTTTC 1080 GATTCATTCG GTTGGGCTTT CCTGTCGGCG TTTCGTCTCA TGACCCAAGA TTTCTGGGAG 1140 GATCTGTATC AGCACGTGCT GCAAGCAGCT GGACCCTGGC ACATGTTGTT CTTTATAGTC 1200 ATCATCTTCC TAGGTTCATT CTATCTTGTG AATTTGATTT TGGCCATTGT TGCCATGTCT 1260 TATGACGAAT TGCAAAAGAA GGCCGAAGAA GAAGAGGCTG CCGAGGAGGA GGCGATACGA 1320 GAAGCTGAAG AAGCGGCAGC AGCCAAGGCG GCCAAACTGG AGGAGCGGGC CAATGTAGCA 1380 GCTCAAGCGG CTCAGGATGC AGCGGATGCC GCTGCGGCAG CTCTGCATCC CGAGATGGCA 1440 AAGAGTCCCA CGTACTCTTG CATTAGCTAT GAACTGTTTG TTGGCGGCGA GAAGGGCAAC 1500 GATGACAACA ACAAAGAGAA GATGTCCATA CGCAGCGTCG AAGTGGAATC GGAGTCGGTG 1560 AGCGTTATAC AAAGACAACC AGCACCTACC ACAGCACCCG CTACTAAAGT CCGTAAAGTT 1620 AGCACGACTT CCTTATCCTT ACCTGGTTCA CCATTTAACC TACGCCGGGG ATCACGTAGT 1680 TCACACAAGT ACACAATACG AAATGGGCGT GGACGTTTTG GTATACCAGG TAGCGATCGC 1740 AAGCCATTGG TACTGCAAAC ATATCAGGAT GCCCAGCAGC ATTTGCCCTA TGCCGATGAC 1800 TCGAATGCCG TAACACCAAT GTCCGAAGAG AATGGTGCCA TTATAGTACC AGCCTACTAT 1860 TGTAATTTAG GTTCTAGACA TTCTTCATAT ACCTCGCATC AATCAAGAAT CTCGTATACA 1920 TCACATGGTG ATTTATTGGG TGGCATGGCG GCCATGGGTG CCAGCACAAT GACCAAAGAG 1980 AGCAAATTGC GCAGTCGCAA CACACGCAAT CAATCAATCG GTGCTGCAAC CAATGGTGGC 2040 AGTAGTACGG CTGGTGGTGG CTATCCCGAT GCCAATCACA AGGAACAAAG GGATTATGAA 2100 ATGGGTCAGG ATTATACAGA CGAAGCTGGC AAAATAAAAC ACCACGACAA TCCTTTTATC 2160 GAGCCCGTCC AAACTCAAAC AGTGGTAGAC ATGAAAGATG TTATGGTCTT AAATGATATC 2220 ATTGAACAAG CCGCTGGTCG GCATAGTCGT GCTAGTGAAC GAGGTGAGGA CGATGACGAA 2280 GATGGTCCCA CATTCAAGGA CATCGCCCTC GAATACATCC TAAAAGGCAT CGAAATCTTT 2340 TGTGTATGGG ACTGTTGTTG GGTGTGGTTA AAATTTCAGG AATGGGTGTC CTTTATTGTG 2400 TTCGATCCAT TCGTGGAGCT CTTCATTACC CTGTGTATTG TGGTCAATAC GATGTTTATG 2460 GCCATGGATC ATCACGACAT GAATCCGGAA TTAGAGAAGG TGCTGAAAAG TGGTAACTAT 2520 TTCTTCACGG CCACTTTTGC AATTGAAGCC AGCATGAAAC TGATGGCCAT GAGCCCGAAG 2580 TACTACTTCC AGGAAGGCTG GAACATTTTC GATTTCATTA TTGTGGCCTT GTCTCTGCTG 2640 GAATTGGGCC TGGAGGGTGT CCAGGGCCTG TCGGTGTTGA GAAGTTTTCG TTTGCTTCGT 2700 GTATTCAAAT TGGCAAAATC ATGGCCCACA CTCAATTTAC TCATTTCGAT TATGGGCCGG 2760 ACAATGGGTG CATTGGGTAA . TCTGACATTT GTACTTTGCA TTATCATCTT CATCTTTGCC 2820 GTGATGGGAA TGCAACTTTT CGGAAAGAAC TATATTGACC ACAAGGATCG CTTCAAGGAC 2880 CATGAATTAC CGCGCTGGAA CTTCACCGAC TTCATGCACA GCTTCATGAT TGTGTTCCGA 2940 GTGCTGTGCG GAGAGTGGAT CGAGTCCATG TGGGACTGCA TGTATGTGGG CGATGTCAGC 3000 TGTATACCCT TCTTCTTGGC CACGGTCGTG ATAGGCAATC TTGTGGTTCT TAATCTTTTC 3060 TTAGCTTTGC TTTTGTCCAA CTTCGGTTCA TCTAGTTTAT CAGCCCCGAC TGCCGACAAT 3120 GATACCAATA AAATAGCAGA GGCCTTCAAT CGTATTGCTC GTTTTAAGAA CTGGGTGAAA 3180 CGTAATATTG CCGATTGTTT TAAGTTAATT CGAAATAAAT TGACAAATCA AATAAGTGAC 3240 CAACCATCAG AACATGGCGA TAATGAACTG GAGTTGGGTC ATGACGAAAT CATGGGCGAT 3300 GGCTTGATCA AAAAGGGTAT GAAGGGCGAG ACCCAGCTGG AGGTGGCCAT TGGCGATGGC 3360 ATGGAGTTCA CGATACATGG CGATATGAAA AACAACAAGC CGAAGAAATC AAAATTCATG 3420 AACAACACAA CGATGATTGG AAACTCAATA AACCACCAAG ACAATAGACT GGAACATGAG 3480 CTAAACCATA GAGGTTTGTC CATACAGGAC GATGACACTG CCAGCATTAA CTCATATGGT 3540 AGCCATAAGA ATCGACCATT CAAGGACGAG AGCCACAAGG GCAGCGCCGA GACCATCGAG 3600 GGCGAGGAGA AACGCGACGT CAGCAAAGAG GACCTCGGCC TCGACGAGGA ACTGGACGAG 3660 GAGGCCGAGG GCGATGAGGG CCAGCTGGAT GGTGACATTA TCATTCATGC GCAAAACGAC 37.50 GACGAGATAA TCGACGACTA TCCGGCCGAC TGTTTCCCCG ACTCGTACTA CAAGAAGTTT 3780 CCGATCTTGG CCGGCGACGA GGACTCGCCG TTCTGGCAAG GATGGGGCAA TTTACGACTG 3840 AAAACTTTTC AATTAATTGA AAATAAATAT TTTGAAACCG CAGTTATCAC TATGATTTTA 3900 ATGAGTAGCT TAGCTTTGGC CTTAGAAGAT GTTCATTTAC CCGATCGACC TGTCATGCAG 3960 GATATACTGT ACTACATGGA CAGGATATTT ACGGTGATAT TCTTTTTGGA GATGTTGATC 4020 AAATGGTTGG CCCTGGGCTT TAAGGTTTAC TTCACCAATG CCTGGTGTTG GCTGGATTTC 4080 GTGATTGTCA TGCTATCGCT TATAAATTTG GTTGCCGTTT GGTCGGGCTT AAATGATATA 4140 GCCGTGTTTA GATCAATGCG CACACTGCGC GCCCTAAGGC CATTGCGTGC TGTCTCTAGA 4200 TGGGAGGGTA TGAAAGTTGT CGTGAATGCG CTGGTTCAAG CTATACCGTC CATCTTCAAT 4260 GTGCTATTGG TGTGTCTGAT ATTTTGGCTT ATTTTTGCCA TTATGGGAGT ACAGCTTTTT 4320 GCTGGAAAAT ATTTTAAGTG TAAAGATGGT AATGACACTG TGCTGAGCCA TGAAATCATA 4380 CCGAATCGTA ATGCCTGCAA AAGTGAAAAC TACACCTGGG AAAATTCGGC AATGAACTTC 4440 GATCATGTAG GTAATGCGTA TCTCTGTCTA TTTCAAGTGG CCACCTTTAA GGGCTGGATC 4500 CAGATTATGA ACGATGCCAT TGATTCACGA GAGGTGGACA AGCAGCCGAT CCGAGAAACC 4560 AATATCTACA TGTATTTATA TTTCGTATTC TTCATTATAT TTGGATCATT TTTCACACTC 4620 AATCTGTTCA TTGGTGTTAT CATTGATAAT TTTAATGAAC AAAAGAAGAA AGCTGGTGGA 4680 TCATTAGAAA TGTTCATGAC AGAAGATCAG AAAAAGTACT ATAATGCTAT GAAAAAGATG 4740 GGCTCTAAAA AACCATTAAA AGCCATTCCA AGACCGAGGT GGCGACCACA AGCAATAGTA 4800 TTCGAAATAG TTACAGATAA AAAATTCGAT ATAATCATTA TGTTGTTCAT TGGCTTAAAC 4860 ATGTTTACCA TGACCCTCGA TCGGTACGAC GCCTCCGAGG CGTACAACAA TGTCCTCGAC 4920 AAACTCAATG GGATATTCGT AGTTATTTTC AGTGGCGAAT GTCTATTAAA AATATTCGCT 4980 TTACGATATC ACTATTTCAA AGAGCCATGG AATTTATTTG ATGTAGTAGT TGTCATTTTA 5040 TCCATCTTAG GTCTTGTACT CAGCGACATC ATTGAGAAGT ATTTCGTATC GCCGACACTG 5100 CTCCGTGTGG TGAGAGTGGC CAAAGTGGGT CGTGTCCTGC GTTTAGTCAA GGGTGCCAAG 5160 GGTATCCGGA CGTTGCTGTT CGCGTTAGCC ATGTCGTTGC CTGCCTTATT CAACATTTGT 5220 CTGTTGCTGT TCTTGGTGAT GTTCATCTTT GCTATCTTTG GCATGTCCTT CTTCATGCAT 5280 GTCAAAGAGA AGAGCGGCAT AAATGCTGTG TATAATTTTA AGACATTTGG CCAAAGTATG 5340 ATATTGCTGT TTCAGATGTC TACCTCAGCC GGTTGGGATG GTGTGTTAGA TGCCATTATC 5400 AATGAGGAAG ATTGCGATCC ACCCGACAAC GACAAGGGCT ATCCGGGCAA TTGTGGTTCA 5460 GCGACTGTTG GAATTACGTT TCTCCTTTCA TATCTAGTTA TAAGCTTTTT GATAGTTATT 5520 AATATGTACA TTGCTGTCAT TCTCGAGAAC TATAGCCAGG CTACGGAGGA TGTACAGGAG 5580 GGTCTCACCG ACGACGATTA CGATATGTAC TACGAGATTT GGCAACAATT CGATCCGGAG 5640 GGCACCCAGT ACATACGCTA CGACCAGCTG TCCGAGTTTC TGGACGTGCT GGAGCCGCCG 5700 CTGCAGATCC ACAAGCCGAA CAAGTACAAA ATCATATCGA TGGACATGCC GATATGTCGG 5760 GGCGACATGA TGTACTGTGT GGATATATTG GATGCCCTGA CCAAGGACTT CTTTGCGCGC 5820 AAGGGTAATC CGATCGAGGA GACGGGTGAA ATTGGTGAGA TAGCGGCGCG ACCGGACACC 5880 GAGGGCTATG ATCCGGTGTC GTCAACACTG TGGCGCCAGC GTGAGGAGTA CTGCGCCAAG 5940 CTGATACAGA ATGCGTGGCG GCGTTACAAG AATGGCCCAC CCCAGGAGGG TGATGAGGGC 6000 GAGGCGGCTG GTGGCGAAGA TGGTGCTGAA GGCGGTGAGG GTGAAGGAGG CAGCGGCGGC 6060 GGCGGCGGTG ATGATGGTGG CTCAGCGACA GGAGCAACGG CGGCGGCGGG AGCCACATCA 6120 CCCTCAGATC CAGATGCCGG CGAAGCAGAT GGTGCCAGCG TCGGCGGCCC CCTTAGTCCG 6180 GGCTGTGTTA GTGGCGGCAG TAATGGCCGC CAAACGGCCG TACTGGTCGA AAGCGATGGT 6240 TTTGTTACAA AAAACGGTCA TAAGGTTGTA ATACACTCGA GATCGCCGAG CATAACATCC 6300 AGGACGGCAG ATGTCTGA 6318 (2) INFORMATION FOR SEQ ID NO : 2 : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 6315 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS : single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 2: ATGACAGAAG ATTCCGACTC GATATCTGAG GAAGAACGCA GTTTGTTCCG TCCCTTCACC 60 CGCGAATCAT TGTTACAAAT CGAACAACGT ATCGCTGAAC ATGAAAAACA AAAGGAGCTG 120 GAAAGAAAGA GAGCCGCCGA AGGAGAGCAG ATACGATATG ATGACGAGGA CGAAGATGAA 180 GGTCCACAGC CGGATCCCAC ACTTGAACAG GGTGTGCCTA TACCTGTTCG AATGCAGGGC 240 AGCTTCCCGC CGGAATTGGC CTCCACTCCT CTCGAGGATA TCGATCCCTT CTACAGTAAT 300 GTACTGACAT TTGTAGTAAT AAGTAAAGGA AAGGATATTT TTCGTTTTTC TGCCTCAAAA 360 GCAATGTGGC TGCTCGATCC ATTCAATCCG ATACGTCGTG TAGCCATTTA TATTTTAGTG 420 CATCCCTTGT TTTCGTTATT CATTATCACC ACTATTCTAA CTAATTGTAT TTTAATGATA 480 ATGCCGACAA CGCCCACGGT CGAATCCACA GAGGTGATAT TCACCGGAAT CTACACATTT 540 GAATCAGCTG TTAAAGTGAT GGCACGAGGT TTCATTTTAT GCCCGTTTAC GTATCTTAGA 600 GATGCATGGA ATTGGCTGGA CTTCGTAGTA ATAGCTTTAG CTTATGTGAC CATGGGCATA 660 GATTTAGGTA ATCTCGCAGC TTTGAGAACA TTTAGGGTAC TGCGAGCTCT GAAAACCGTA 720 GCCATTGTGC CAGGTCTAAA AACCATTGTC GGTGCTGTCA TTGAATCTGT AAAAAATCTA 780 CGCGATGTGA TAATTTTGAC AATGTTTTCC CTGTCGGTGT TCGCGCTGAT GGGCCTACAA 840 ATCTATATGG GTGTTCTAAC ACAAAAGTGC ATTAAACGAT TCCCCCTGGA CGGCAGTTGG 900 GGCAATCTGA CCGATGAAAA CTGGTTTCTA CACAATAGCA ACAGTTCCAA TTGGTTTACG 960 GAGAACGATG GCGAGTCATA TCCGGTGTGC GGGAATGTAT CCGGTGCGGG ACAATGCGGC 1020 GAAGATTACG TCTGCCTGCA GGGCTTCGGC CCCAATCCCA ACTACGACTA CACCAGTTTC 1080 GACTCATTCG GTTGGGCTTT CCTGTCGGCG TTTCGTCTCA TGACCCAAGA TTTCTGGGAG 1140 GATCTGTATC AGCACGTGCT GCAAGCAGCT GGACCCTGGC ACATGTTGTT CTTTATAGTC 1200 ATCATCTTCC TAGGTTCATT CTATCTTGTG AATTTGATTT TGGCCATTGT TGCCATGTCT 1260 TATGACGAAT TGCAAAAGAA GGCCGAAGAA GAAGAGGCTG CCGAGGAGGA GGCGATCCGA 1320 GAAGCTGAAG AAGCGGCAGC AGCCAAGGCG GCCAAACTGG AGGAGCGGGC CAATGTAGCA 1380 GCTCAAGCGG CTCAGGATGC AGCGGATGCC GCTGCGGCAG CTCTGCATCC CGAGATGGCA 1440 AAGAGTCCCA CGTACTCTTG CATTAGCT T GAACTGTTTG TTGGCGGCGA GAAGGGCAAC 1500 GATGACAACA ACAAGGAGAA GATGTCGATA CGCAGCGTCG AAGTGGAATC GGAGTCGGTG 1560 AGCGTTATAC AAAGACAACC AGCACCTACC ACAGCACCCG CTACTAAAGT CCGTAAAGTT 1620 AGCACGACTT CCTTATCCTT ACCTGGTTCA CCATTTAACC TACGCCGGGG ATCACGTAGT 1680 TCACACAAGT ACACAATACG AAATGGGCGT GGACGTTTTG GTATACCAGG TAGCGATCGC 1740 AAGCCATTGG TACTGCAAAC ATATCAGGAT GCCCAGCAGC ATTTGCCCTA TGCCGATGAC 1800 TCGAATGCCG TAACACCAAT GTCCGAAGAG AATGGTGCCA TTATAGTACC AGCCTACTAT 1860 TGTAATTTAG GTTCTAGACA TTCTTCATAT ACCTCGCATC AATCAAGAAT CTCGTATACA 1920 TCACATGGTG ATTTATTGGG TGGCATGGCG GCCATGGGTG CCAGCACAAT GACCAAAGAG 1980 AGCAAATTGC GCAGTCGCAA CACACGCAAT CAATCAATCG GTGCTGCAAC CAATGGTGGC 2040 AGTAGTACGG CCGGTGGTGG CTATCCCGAT GCCAATCACA AGGAACAAAG GGATTATGAA 2100 ATGGGTCAGG ATTATACAGA CGAAGCTGGC AAAATAAAAC ACCACGACAA TCCTTTTATC 2160 GAGCCCGTCC AAACTCAAAC AGTGGTAGAC ATGAAAGATG TTATGGTCTT AAATGATATC 2220 ATTGAACAAG CCGCTGGTCG GCATAGTCGT GCTAGTGAAC GAGGTGAGGA CGATGACGAA 2280 GATGGTCCCA CATTCAAGGA CATCGCCCTC GAATATATCC TAAAAGGCAT CGAAATCTTT 2340 TGTGTATGGG ACTGTTGTTG GGTGTGGTTA AAATTTCAGG AATGGGTCTC CTTTATTGTG 2400 TTCGATCCAT TCGTGGAGCT CTTCATTACC CTGTGTATTG TGGTCAATAC AATGTTCATG 2460 GCCATGGATC ATCACGACAT GAATCCGGAA TTGGAGAAGG TGCTGAAAAG TGGTAACTAT 2520 TTCTTCACGG CCACTTTTGC AATTGAGGCC AGCATGAAAC TGATGGCCAT GAGCCCGAAG 2580 TACTACTTCC AGGAAGGCTG GAACATTTTC GATTTCATTA TTGTGGCCTT GTCTCTGCTG 2640 GAATTGGGCC TGGAGGGTGT CCAGGGCCTG TCGGTGTTGA GAAGTTTTCG TTTGCTTCGT 2700 GTATTCAAAT TGGCAAAATC ATGGCCCACA CTGAATTTAC TCATTTCGAT TATGGGCCGG 2760 ACAATGGGTG CATTGGGTAA TCTGACATTT GTACTTTGCA TTATCATCTT CATCTTTGCC 2820 GTGATGGGAA TGCAACTTTT CGGAAAGAAC TATATTGACC ACAAGGATCG CTTCAAGGAC 2880 CATGAATTAC CGCGCTGGAA TTTCACCGAC TTCATGCACA GCTTCATGAT TGTGTTCCGA 2940 GTGCTGTGCG GAGAGTGGAT CGAGTCCATG TGGGACTGCA TGTATGTGGG CGATGTCAGC 3000 TGTATACCCT TCTTCTTGGC CACGGTCGTG ATCGGCAATT TTGTGGTTCT TAATCTTTTC 3060 TTAGCTTTGC TTTTGTCCAA CTTCGGTTCA TCTAGTTTAT CAGCCCCGAC TGCCGACAAT 3120 GATACCAATA AAATAGCAGA GGCCTTCAAT CGTATTGCTC GTTTTAAGAA CTGGGTGAAA 3180 CGTAATATTG CCGATTGTTT TAAGTTAATT CGAAATAAAT TGACAAATCA AATAAGTGAC 3240 CAACCATCAG AACATGGCGA TAATGAACTG GAGTTGGGTC ATGACGAAAT CATGGGCGAT 3300 GGCTTGATCA AAAAGGGTAT GAAGGGCGAG ACCCAGCTGG AGGTGGCCAT TGGCGATGGC 3360 ATGGAGTTCA CGATACATGG CGATATGAAA AACAACAAGC CCAAGAAATC AAAATTCATA 3420 AACAACACAA CGATGATTGG AAACTCAATA AACCACCAAG ACAATAGACT GGAACATGAG 3480 CTAAACCATA GAGGTTTGTC CATACAGGAC GATGACACTG CCAGCATTAA CTCATATGGT 3540 AGCCATAAGA ATCGACCATT CAAGGACGAG AGCCACAAGG GCAGCGCCGA GACCATCGAG 3600 GGCGAGGAGA AACGCGACGT CAGCAAAGAG GACCTCGGCC TCGACGAGGA ACTGGACGAG 3660 GAGGCCGAGG GCGATGAGGG CCAGCTGGAT GGTGACATCA TCATTCATGC CCAAAACGAC 3720 GACGAGATAA TCGACGACTA TCCGGCCGAC TGTTTCCCCG ACTCGTACTA CAAGAAGTTT 3780 CCGATCTTGG CCGGCGACGA GGACTCGCCG TTCTGGCAAG GATGGGGCAA TTTACGACTG 3840 AAAACTTTTC AATTAATTGA AAATAAATAT TTTGAAACCG CAGTTATCAC TATGATTTTA 3900 ATGAGTAGCT TAGCTTTGGC CTTAGAAGAT GTTCATTTAC CCGATCGACC TGTCATGCAG 3960 GATATACTGT ACTACATGGA CAGGATATTT ACGGTGATAT TCTTTTTGGA GATGTTGATC 4020 AAATGGTTGG CCCTGGGCTT TAAGGTCTAC TTCACCAATG CCTGGTGTTG GCTGGATTTC 4080 GTGATTGTCA TGCTATCGCT TATAAATTTG GTTGCCGTTT GGTCGGGCTT AAATGATATA 4140 GCCGTGTTTA GATCAATGCG CACACTGCGC GCCCTAAGGC CATTGCGTGC TGTCTCTAGA 4200 TGGGAGGGTA TGAAAGTTGT CGTGAATGCG CTGGTTCAAG CTATACCGTC CATCTTCAAT 4260 GTGCTATTGG TGTGTCTGAT ATTTTGGCTT ATTTTTGCCA TTATGGGAGT ACAGCTTTTT 4320 GCTGGAAAAT ATTTTAAGTG TAAAGATGGT AATGACACTG TGCTGAGCCA TGAAATCATA 4380 CCGAATCGTA ATGCCTGCAA AAGTGAAAAC TACACCTGGG AAAATTCGGC AATGAACTTC 4440 GATCATGTAG GTAATGCGTA TCTCTGTCTA TTTCAAGTGG CCACCTTTAA GGGCTGGATC 4500 CAGATTATGA ACGATGCCAT TGATTCACGA GAGGTGGACA AGCAGCCGAT CCGAGAAACC 4560 AATATCTACA TGTATTTATA TTTCGTATTC TTCATTATAT TTGGATCATT TTTCACACTC 4620 AATCTGTTCA TTGGTGTTAT CATTGATAAT TTTAATGAAC AAAAGAAGAA AGCAGGTGGA 4680 TCATTAGAAA TGTTCATGAC AGAAGATCAG AAAAAGTACT ATAATGCTAT GAAAAAGATG 4740 GGCTCTAAAA AACCATTAAA AGCCATTCCA AGACCGAGGT GGCGACCACA AGCAATAGTA 4800 TTCGAAATAG TTACAGATAA AAAATTCGAT ATAATCATTA TGTTGTTCAT TGGCTTAAAC 4860 ATGTTTACCA TGACCCTCGA TCGGTACGAC GCCTCCGAGG CGTACAACAA TGTCCTCGAC 4920 AAACTCAATG GGATATTCGT AGTTATTTTC AGTGGCGAAT GTCTATTAAA AATATTCGCT 4980 TTACGATATC ACTATTTCAA AGAGCCATGG AATTTATTTG ATGTAGTAGT TGTCATTTTA 5040 TCCATCTTAG GTCTTGTACT CAGCGACATC ATTGAGAAGT ATTTCGTATC GCCGACACTG 5100 CTCCGTGTGG TGAGAGTGGC CAAAGTGGGT CGTGTCCTGC GTTTAGTCAA GGGTGCCAAG 5160 GGTATCCGGA CGTTGCTGTT CGCGTTAGCC ATGTCGTTGC CTGCCTTATT CAACATTTGT 5220 CTGTTGCTGT TCTTGGTGAT GTTCATCTTT GCTATCTTTG GCATGTCCTT CTTCATGCAT 5280 GTCAAAGAGA AGAGCGGCAT AAATGCTGTG TATAATTTTA AGACATTTGG CCAAAGTATG 5340 ATATTGCTGT TTCAGATGTC TACCTCAGCC GGTTGGGATG GTGTGTTAGA TGCCATTATC 5400 AATGAGGAAG ATTGCGATCC ACCCGACAAC GACAAGGGCT ATCCGGGCAA TTGTGGTTCA 5460 GCGACTGTTG GAATTACGTT TCTCCTTTCA TATCTAGTTA TAAGCTTTTT GATAGTTATT 5520 AATATGTACA TTGCTGTCAT TCTCGAGAAC TATAGCCAGG CTACGGAGGA TGTACAGGAG 5580 GGTCTCACCG ACGACGACTA TGATATGTAC TACGAGATTT GGCAACAATT CGATCCGGAG 5640 GGTACCCAGT ACATAAGATA CGACCAGCTG TCCGAGTTCC TGGACGTGCT GGAGCCGCCG 5700 CTGCAGATCC ACAAGCCGAA CAAGTACAAA ATCATATCGA TGGACATGCC GATATGTCGG 5760 GGCGACATGA TGTACTGTGT GGATATATTG GATGCCCTGA CCAAGGACTT CTTTGCGCGC 5820 AAGGGTAATC CGATCGAGGA GACGGGTGAA ATTGGTGAGA TTGCGGCGCG ACCGGACACC 5880 GAGGGCTATG ATCCGGTGTC GTCGACACTG TGGCGCCAGC GTGAGGAGTA CTGCGCCAAG 5940 CTGATACAGA ATGCGTGGCG GCGTTACAAG AATGGCCCAC CCCAGGAGGG TGATGAGGGC 6000 GAGGCGGCTG GTGGCGAAGA TGGTGCTGAA GGCGGTGAGG GTGAAGGCGG CAGCGGCGGC 6060 GGCGGCGATG ATGATGGTGG CTCAGCGACG GCGGCGGGAG CCACATCACC CACAGATCCA 6120 GATGCCGGCG AAGCAGATGG TGCCAGCGCC GGCAATGGTG GCGGCCCCCT TAGTCCGGGC 6180 TGTGTTAGTG GCGGCAGTAA TGGCCGCCAA ACGGCCGTAC TGGTCGAAAG CGATGGTTTT 6240 GTTACAAAAA ACGGTCATAA GGTTGTAATA CACTCGAGAT CGCCGAGCAT AACATCCAGG 6300 ACGGCAGATG TCTGA 6315 (2) INFORMATION FOR SEQ ID NO: 3: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 2105 amino acids (B) TYPE: amino acid (C) STRANDEDNESS : not relevant (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO : 3 : Met Thr Glu Asp Ser Asp Ser He Ser Glu Glu Glu Arg Ser Leu Phe 1 5 10 15 Arg Pro Phe Thr Arg Glu Ser Leu Leu Gin He Glu Gin Arg He Ala 20 25 30 Glu His Glu Lys Gin Lys Glu Leu Glu Arg Lys Arg Ala Ala Glu Gly 35 40 45 Glu Gin He Arg Tyr Asp Asp Glu Asp Glu Asp Glu Gly Pro Gin Pro 50 55 60 Asp Pro Thr Leu Glu Gin Gly Val Pro He Pro Val Arg Met Gin Gly 65 70 75 80 Ser Phe Pro Pro Glu Leu Ala Ser Thr Pro Leu Glu Asp He Asp Pro 85 90 95 Phe Tyr Ser Asn Val Leu Thr Phe Val Val He Ser Lys Gly Lys Asp 100 105 110 He Phe Arg Phe Ser Ala Ser Lys Ala Met Trp Leu Leu Asp Pro Phe 115 120 125 Asn Pro He Arg Arg Val Ala He Tyr He Leu Val His Pro Leu Phe 130 135 140 Ser Leu Phe He He Thr Thr He Leu Thr Asn Cys He Leu Met He 145 150 155 160 Met Pro Thr Thr Pro Thr Val Glu Ser Thr Glu Val He Phe Thr Gly 165 170 175 He Tyr Thr Phe Glu Ser Ala Val Lys Val Met Ala Arg Gly Phe He 180 185 190 Leu Cys Pro Phe Thr Tyr Leu Arg Asp Ala Trp Asn Trp Leu Asp Phe 195 200 205 Val Val He Ala Leu Ala Tyr Val Thr Met Gly He Asp Leu Gly Asn 210 215 220 Leu Ala Ala Leu Arg Thr Phe Arg Val Leu Arg Ala Leu Lys Thr Val 225 230 235 240 Ala He Val Pro Gly Leu Lys Thr He Val Gly Ala Val He Glu Ser 245 250 255 Val Lys Asn Leu Arg Asp Val He He Leu Thr Met Phe Ser Leu Ser 260 265 270 Val Phe Ala Leu Met Gly Leu Gin He Tyr Met Gly Val Leu Thr Gin 275 280 285 Lys Cys He Lys Arg Phe Pro Leu Asp Gly Ser Trp Gly Asn Leu Thr 290 295 300 Asp Glu Asn Trp Phe Leu His Asn Ser Asn Ser Ser Asn Trp Phe Thr 305 310 315 320 Glu Asn Asp Gly Glu Ser Tyr Pro Val Cys Gly Asn Val Ser Gly Ala 325 330 335 Gly Gin Cys Gly Glu Asp Tyr Val Cys Leu Gin Gly Phe Gly Pro Asn 340 345 350 Pro Asn Tyr Asp Tyr Thr Ser Phe Asp Ser Phe Gly Trp Ala Phe Leu 355 360 365 Ser Ala Phe Arg Leu Met Thr Gin Asp Phe Trp Glu Asp Leu Tyr Gin 370 375 380 His Val Leu Gin Ala Ala Gly Pro Trp His Met Leu Phe Phe He Val 385 390 395 400 He He Phe Leu Gly Ser Phe Tyr Leu Val Asn Leu He Leu Ala He 405 410 415 Val Ala Met Ser Tyr Asp Glu Leu Gin Lys Lys Ala Glu Glu Glu Glu 420 425 430 Ala Ala Glu Glu Glu Ala He Arg Glu Ala Glu Glu Ala Ala Ala Ala 435 440 445 Lys Ala Ala Lys Leu Glu Glu Arg Ala Asn Val Ala Ala Gin Ala Ala 450 455 460 Gin Asp Ala Ala Asp Ala Ala Ala Ala Ala Leu His Pro Glu Met Ala 465 470 475 480 Lys Ser Pro Thr Tyr Ser Cys He Ser Tyr Glu Leu Phe Val Gly Gly 485 490 495 Glu Lys Gly Asn Asp Asp Asn Asn Lys Glu Lys Met Ser He Arg Ser 500 505 510 Val Glu Val Glu Ser Glu Ser Val Ser Val He Gin Arg Gin Pro Ala 515 520 525 Pro Thr Thr Ala Pro Ala Thr Lys Val Arg Lys Val Ser Thr Thr Ser 530 535 540 Leu Ser Leu Pro Gly Ser Pro Phe Asn Leu Arg Arg Gly Ser Arg Ser 545 550 555 560 Ser His Lys Tyr Thr He Arg Asn Gly Arg Gly Arg Phe Gly He Pro 565 570 575 Gly Ser Asp Arg Lys Pro Leu Val Leu Gin Thr Tyr Gin Asp Ala Gin 580 585 590 Gin His Leu Pro Tyr Ala Asp Asp Ser Asn Ala Val Thr Pro Met Ser 595 600 605 Glu Glu Asn Gly Ala He He Val Pro Ala Tyr Tyr Cys Asn Leu Gly 610 615 620 Ser Arg His Ser Ser Tyr Thr Ser His Gin Ser Arg He Ser Tyr Thr 625 630 635 640 Ser His Gly Asp Leu Leu Gly Gly Met Ala Ala Met Gly Ala Ser Thr 645 650 655 Met Thr Lys Glu Ser Lys Leu Arg Ser Arg Asn Thr Arg Asn Gin Ser 660 665 670 He Gly Ala Ala Thr Asn Gly Gly Ser Ser Thr Ala Gly Gly Gly Tyr 675 680 685 Pro Asp Ala Asn His Lys Glu Gin Arg Asp Tyr Glu Met Gly Gin Asp 690 695 700 Tyr Thr Asp Glu Ala Gly Lys He Lys His His Asp Asn Pro Phe He 705 710 715 720 Glu Pro Val Gin Thr Gin Thr Val Val Asp Met Lys Asp Val Met Val 725 730 735 Leu Asn Asp He He Glu Gin Ala Ala Gly Arg His Ser Arg Ala Ser 740 745 750 Glu Arg Gly Glu Asp Asp Asp Glu Asp Gly Pro Thr Phe Lys Asp He 755 760 765 Ala Leu Glu Tyr He Leu Lys Gly He Glu He Phe Cys Val Trp Asp 770 775 780 Cys Cys Trp Val Trp Leu Lys Phe Gin Glu Trp Val Ser Phe He Val 785 790 795 800 Phe Asp Pro Phe Val Glu Leu Phe He Thr Leu Cys He Val Val Asn 805 810 815 Thr Met Phe Met Ala Met Asp His His Asp Met Asn Pro Glu Leu Glu 820 825 830 Lys Val Leu Lys Ser Gly Asn Tyr Phe Phe Thr Ala Thr Phe Ala He 835 840 845 Glu Ala Ser Met Lys Leu Met Ala Met Ser Pro Lys Tyr Tyr Phe Gin 850 855 860 Glu Gly Trp Asn He Phe Asp Phe He He Val Ala Leu Ser Leu Leu 865 870 875 880 Glu Leu Gly Leu Glu Gly Val Gin Gly Leu Ser Val Leu Arg Ser Phe 885 890 895 Arg Leu Leu Arg Val Phe Lys Leu Ala Lys Ser Trp Pro Thr Leu Asn 900 905 910 Leu Leu He Ser He Met Gly Arg Thr Met Gly Ala Leu Gly Asn Leu 915 920 925 Thr Phe Val Leu Cys He He He Phe He Phe Ala Val Met Gly Met 930 935 940 Gin Leu Phe Gly Lys Asn Tyr He Asp His Lys Asp Arg Phe Lys Asp 945 950 955 960 His Glu Leu Pro Arg Trp Asn Phe Thr Asp Phe Met His Ser Phe Met 965 970 975 He Val Phe Arg Val Leu Cys Gly Glu Trp He Glu Ser Met Trp Asp 980 985 990 Cys Met Tyr Val Gly Asp Val Ser Cys He Pro Phe Phe Leu Ala Thr 995 1000 1005 Val Val He Gly Asn Leu Val Val Leu Asn Leu Phe Leu Ala Leu Leu 1010 1015 1020 Leu Ser Asn Phe Gly Ser Ser Ser Leu Ser Ala Pro Thr Ala Asp Asn 1025 1030 1035 1040 Asp Thr Asn Lys He Ala Glu Ala Phe Asn Arg He Ala Arg Phe Lys 1045 1050 1055 Asn Trp Val Lys Arg Asn He Ala Asp Cys Phe Lys Leu He Arg Asn 1060 1065 1070 Lys Leu Thr Asn Gin He Ser Asp Gin Pro Ser Glu His Gly Asp Asn 1075 1080 1085 Glu Leu Glu Leu Gly His Asp Glu He Met Gly Asp Gly Leu He Lys 1090 1095 1100 Lys Gly Met Lys Gly Glu Thr Gin Leu Glu Val Ala He Gly Asp Gly 1105 1110 1115 1120 Met Glu Phe Thr He His Gly Asp Met Lys Asn Asn Lys Pro Lys Lys 1125 1130 1135 Ser Lys Phe Met Asn Asn Thr Thr Met He Gly Asn Ser He Asn His 1140 1145 1150 Gin Asp Asn Arg Leu Glu His Glu Leu Asn His Arg Gly Leu Ser He 1155 1160 1165 Gin Asp Asp Asp Thr Ala Ser He Asn Ser Tyr Gly Ser His Lys Asn 1170 1175 1180 Arg Pro Phe Lys Asp Glu Ser His Lys Gly Ser Ala Glu Thr He Glu 1185 1190 1195 1200 Gly Glu Glu Lys Arg Asp Val Ser Lys Glu Asp Leu Gly Leu Asp Glu 1205 1210 1215 Glu Leu Asp Glu Glu Ala Glu Gly Asp Glu Gly Gin Leu Asp Gly Asp 1220 1225 1230 He He He His Ala Gin Asn Asp Asp Glu He He Asp Asp Tyr Pro 1235 1240 1245 Ala Asp Cys Phe Pro Asp Ser Tyr Tyr Lys Lys Phe Pro He Leu Ala 1250 1255 1260 Gly Asp Glu Asp Ser Pro Phe Trp Gin Gly Trp Gly Asn Leu Arg Leu 1265 1270 1275 1280 Lys Thr Phe Gin Leu He Glu Asn Lys Tyr Phe Glu Thr Ala Val He 1285 1290 1295 Thr Met He Leu Met Ser Ser Leu Ala Leu Ala Leu Glu Asp Val His 1300 1305 1310 Leu Pro Asp Arg Pro Val Met Gin Asp He Leu Tyr Tyr Met Asp Arg 1315 1320 1325 He Phe Thr Val He Phe Phe Leu Glu Met Leu He Lys Trp Leu Ala 1330 1335 1340 Leu Gly Phe Lys Val Tyr Phe Thr Asn Ala Trp Cys Trp Leu Asp Phe 1345 1350 1355 1360 Val He Val Met Leu Ser Leu He Asn Leu Val Ala Val Trp Ser Gly 1365 1370 1375 Leu Asn Asp He Ala Val Phe Arg Ser Met Arg Thr Leu Arg Ala Leu 1380 1385 1390 Arg Pro Leu Arg Ala Val Ser Arg Trp Glu Gly Met Lys Val Val Val 1395 1400 1405 Asn Ala Leu Val Gin Ala He Pro Ser He Phe Asn Val Leu Leu Val 1410 1415 1420 Cys Leu He Phe Trp Leu He Phe Ala He Met Gly Val Gin Leu Phe 1425 1430 1435 1440 Ala Gly Lys Tyr Phe Lys Cys Lys Asp Gly Asn Asp Thr Val Leu Ser 1445 1450 1455 His Glu He He Pro Asn Arg Asn Ala Cys Lys Ser Glu Asn Tyr Thr 1460 1465 1470 Trp Glu Asn Ser Ala Met Asn Phe Asp His Val Gly Asn Ala Tyr Leu 1475 1480 1485 Cys Leu Phe Gin Val Ala Thr Phe Lys Gly Trp He Gin He Met Asn 1490 1495 1500 Asp Ala He Asp Ser Arg Glu Val Asp Lys Gin Pro He Arg Glu Thr 1505 1510 1515 1520 Asn He Tyr Met Tyr Leu Tyr Phe Val Phe Phe He He Phe Gly Ser 1525 1530 1535 Phe Phe Thr Leu Asn Leu Phe He Gly Val He He Asp Asn Phe Asn 1540 1545 1550 Glu Gin Lys Lys Lys Ala Gly Gly Ser Leu Glu Met Phe Met Thr Glu 1555 1560 1565 Asp Gin Lys Lys Tyr Tyr Asn Ala Met Lys Lys Met Gly Ser Lys Lys 1570 1575 1580 Pro Leu Lys Ala He Pro Arg Pro Arg Trp Arg Pro Gin Ala He Val 1585 1590 1595 1600 Phe Glu He Val Thr Asp Lys Lys Phe Asp He He He Met Leu Phe 1605 1610 1615 He Gly Leu Asn Met Phe Thr Met Thr Leu Asp Arg Tyr Asp Ala Ser 1620 1625 1630 Glu Ala Tyr Asn Asn Val Leu Asp Lys Leu Asn Gly He Phe Val Val 1635 1640 1645 He Phe Ser Gly Glu Cys Leu Leu Lys He Phe Ala Leu Arg Tyr His 1650 1655 1660 Tyr Phe Lys Glu Pro Trp Asn Leu Phe Asp Val Val Val Val He Leu 1665 1670 1675 1680 Ser He Leu Gly Leu Val Leu Ser Asp He He Glu Lys Tyr Phe Val 1685 1690 1695 Ser Pro Thr Leu Leu Arg Val Val Arg Val Ala Lys Val Gly Arg Val 1700 1705 1710 Leu Arg Leu Val Lys Gly Ala Lys Gly He Arg Thr Leu Leu Phe Ala 1715 1720 1725 Leu Ala Met Ser Leu Pro Ala Leu Phe Asn He Cys Leu Leu Leu Phe 1730 1735 1740 Leu Val Met Phe He Phe Ala He Phe Gly Met Ser Phe Phe Met His 1745 1750 1755 1760 Val Lys Glu Lys Ser Gly He Asn Ala Val Tyr Asn Phe Lys Thr Phe 1765 1770 1775 Gly Gin Ser Met He Leu Leu Phe Gin Met Ser Thr Ser Ala Gly Trp 1780 1785 1790 Asp Gly Val Leu Asp Ala He He Asn Glu Glu Asp Cys Asp Pro Pro 1795 1800 1805 Asp Asn Asp Lys Gly Tyr Pro Gly Asn Cys Gly Ser Ala Thr Val Gly 1810 1815 1820 He Thr Phe Leu Leu Ser Tyr Leu Val He Ser Phe Leu He Val He 1825 1830 1835 1840 Asn Met Tyr He Ala Val He Leu Glu Asn Tyr Ser Gin Ala Thr Glu 1845 1850 1855 Asp Val Gin Glu Gly Leu Thr Asp Asp Asp Tyr Asp Met Tyr Tyr Glu 1860 1865 1870 He Trp Gin Gin Phe Asp Pro Glu Gly Thr Gin Tyr He Arg Tyr Asp 1875 1880 1885 Gin Leu Ser Glu Phe Leu Asp Val Leu Glu Pro Pro Leu Gin He His 1890 1895 1900 Lys Pro Asn Lys Tyr Lys He He Ser Met Asp Met Pro He Cys Arg 1905 1910 1915 1920 Gly Asp Met Met Tyr Cys Val Asp He Leu Asp Ala Leu Thr Lys Asp 1925 1930 1935 Phe Phe Ala Arg Lys Gly Asn Pro He Glu Glu Thr Gly Glu lie Gly 1940 1945 1950 Glu He Ala Ala Arg Pro Asp Thr Glu Gly Tyr Asp Pro Val Ser Ser 1955 1960 1965 Thr Leu Trp Arg Gin Arg Glu Glu Tyr Cys Ala Lys Leu He Gin Asn 1970 1975 1980 Ala Trp Arg Arg Tyr Lys Asn Gly Pro Pro Gin Glu Gly Asp Glu Gly 1985 1990 1995 2000 Glu Ala Ala Gly Gly Glu Asp Gly Ala Glu Gly Gly Glu Gly Glu Gly 2005 2010 2015 Gly Ser Gly Gly Gly Gly Gly Asp Asp Gly Gly Ser Ala Thr Gly Ala 2020 2025 2030 Thr Ala Ala Ala Gly Ala Thr Ser Pro Ser Asp Pro Asp Ala Gly Glu 2035 2040 2045 Ala Asp Gly Ala Ser Val Gly Gly Pro Leu Ser Pro Gly Cys Val Ser 2050 2055 2060 Gly Gly Ser Asn Gly Arg Gin Thr Ala Val Leu Val Glu Ser Asp Gly 2065 2070 2075 2080 Phe Val Thr Lys Asn Gly His Lys Val Val He His Ser Arg Ser Pro 2085 2090 2095 Ser He Thr Ser Arg Thr Ala Asp Val 2100 2105 (2) INFORMATION FOR SEQ ID NO : 4 : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 2104 amino acids (B) TYPE: amino acid (C) STRANDEDNESS : not relevant (D) TOPOLOGY: linear ( ii ) MOLECULE TYPE : protein (xi ) SEQUENCE DESCRIPTION : SEQ ID N0 : 4 : Met Thr Glu Asp Ser Asp Ser He Ser Glu Glu Glu Arg Ser Leu Phe 1 5 10 15 Arg Pro Phe Thr Arg Glu Ser Leu Leu Gin He Glu Gin Arg He Ala 20 25 30 Glu His Glu Lys Gin Lys Glu Leu Glu Arg Lys Arg Ala Ala Glu Gly 35 40 45 Glu Gin He Arg Tyr Asp Asp Glu Asp Glu Asp Glu Gly Pro Gin Pro 50 55 60 Asp Pro Thr Leu Glu Gin Gly Val Pro He Pro Val Arg Met Gl ' n Gly 65 70 75 80 Ser Phe Pro Pro Glu Leu Ala Ser Thr Pro Leu Glu Asp He Asp Pro 85 90 95 Phe Tyr Ser Asn Val Leu Thr Phe Val Val He Ser Lys Gly Lys Asp 100 105 110 He Phe Arg Phe Ser Ala Ser Lys Ala Met Trp Leu Leu Asp Pro Phe 115 120 125 Asn Pro He Arg Arg Val Ala He Tyr He Leu Val His Pro Leu Phe 130 135 140 Ser Leu Phe He He Thr Thr He Leu Thr Asn Cys He Leu Met He 145 150 155 160 Met Pro Thr Thr Pro Thr Val Glu Ser Thr Glu Val He Phe Thr Gly 165 170 175 He Tyr Thr Phe Glu Ser Ala Val Lys Val Met Ala Arg Gly Phe He 180 185 190 Leu Cys Pro Phe Thr Tyr Leu Arg Asp Ala Trp Asn Trp Leu Asp Phe 195 200 205 Val Val He Ala Leu Ala Tyr Val Thr Met Gly He Asp Leu Gly Asn 210 215 220 Leu Ala Ala Leu Arg Thr Phe Arg Val Leu Arg Ala Leu Lys Thr Val 225 230 235 240 Ala He Val Pro Gly Leu Lys Thr He Val Gly Ala Val He Glu Ser 245 250 255 Val Lys Asn Leu Arg Asp Val He He Leu Thr Met Phe Ser Leu Ser 260 265 270 Val Phe Ala Leu Met Gly Leu Gin He Tyr Met Gly Val Leu Thr Gin 275 280 285 Lys Cys He Lys Arg Phe Pro Leu Asp Gly Ser Trp Gly Asn Leu Thr 290 295 300 Asp Glu Asn Trp Phe Leu His Asn Ser Asn Ser Ser Asn Trp Phe Thr 305 310 315 320 Glu Asn Asp Gly Glu Ser Tyr Pro Val Cys Gly Asn Val Ser Gly Ala 325 330 335 Gly Gin Cys Gly Glu Asp Tyr Val Cys Leu Gin Gly Phe Gly Pro Asn 340 345 350 Pro Asn Tyr Asp Tyr Thr Ser Phe Asp Ser Phe Gly Trp Ala Phe Leu 355 360 365 Ser Ala Phe Arg Leu Met Thr Gin Asp Phe Trp Glu Asp Leu Tyr Gin 370 375 380 His Val Leu Gin Ala Ala Gly Pro Trp His Met Leu Phe Phe He Val 385 390 395 400 He He Phe Leu Gly Ser Phe Tyr Leu Val Asn Leu He Leu Ala He 405 410 415 Val Ala Met Ser Tyr Asp Glu Leu Gin Lys Lys Ala Glu Glu Glu Glu 420 425 430 Ala Ala Glu Glu Glu Ala He Arg Glu Ala Glu Glu Ala Ala Ala Ala 435 440 445 Lys Ala Ala Lys Leu Glu Glu Arg Ala Asn Val Ala Ala Gin Ala Ala 450 455 460 Gin Asp Ala Ala Asp Ala Ala Ala Ala Ala Leu His Pro Glu Met Ala 465 470 475 480 Lys Ser Pro Thr Tyr Ser Cys He Ser Tyr Glu Leu Phe Val Gly Gly 485 490 495 Glu Lys Gly Asn Asp Asp Asn Asn Lys Glu Lys Met Ser He Arg Ser 500 505 510 Val Glu Val Glu Ser Glu Ser Val Ser Val He Gin Arg Gin Pro Ala 515 520 525 Pro Thr Thr Ala Pro Ala Thr Lys Val Arg Lys Val Ser Thr Thr Ser 530 535 540 Leu Ser Leu Pro Gly Ser Pro Phe Asn Leu Arg Arg Gly Ser Arg Ser 545 550 555 560 Ser His Lys Tyr Thr He Arg Asn Gly Arg Gly Arg Phe Gly He Pro 565 570 575 Gly Ser Asp Arg Lys Pro Leu Val Leu Gin Thr Tyr Gin Asp Ala Gin 580 585 590 Gin His Leu Pro Tyr Ala Asp Asp Ser Asn Ala Val Thr Pro Met Ser 595 600 605 Glu Glu Asn Gly Ala He He Val Pro Ala Tyr Tyr Cys Asn Leu Gly 610 615 620 Ser Arg His Ser Ser Tyr Thr Ser His Gin Ser Arg He Ser Tyr Thr 625 630 635 640 Ser His Gly Asp Leu Leu Gly Gly Met Ala Ala Met Gly Ala Ser Thr 645 650 655 Met Thr Lys Glu Ser Lys Leu Arg Ser Arg Asn Thr Arg Asn Gin Ser 660 665 670 He Gly Ala Ala Thr Asn Gly Gly Ser Ser Thr Ala Gly Gly Gly Tyr 675 680 685 Pro Asp Ala Asn His Lys Glu Gin Arg Asp Tyr Glu Met Gly Gin Asp 690 695 700 Tyr Thr Asp Glu Ala Gly Lys He Lys His His Asp Asn Pro Phe He 705 710 715 720 Glu Pro Val Gin Thr Gin Thr Val Val Asp Met Lys Asp Val Met Val 725 730 735 Leu Asn Asp He He Glu Gin Ala Ala Gly Arg His Ser Arg Aϊ * a Ser 740 745 750 Glu Arg Gly Glu Asp Asp Asp Glu Asp Gly Pro Thr Phe Lys Asp He 755 760 765 Ala Leu Glu Tyr He Leu Lys Gly He Glu He Phe Cys Val Trp Asp 770 775 780 Cys Cys Trp Val Trp Leu Lys Phe Gin Glu Trp Val Ser Phe He Val 785 790 795 800 Phe Asp Pro Phe Val Glu Leu Phe He Thr Leu Cys He Val Val Asn 805 810 815 Thr Met Phe Met Ala Met Asp His His Asp Met Asn Pro Glu Leu Glu 820 825 830 Lys Val Leu Lys Ser Gly Asn Tyr Phe Phe Thr Ala Thr Phe Ala He 835 840 845 Glu Ala Ser Met Lys Leu Met Ala Met Ser Pro Lys Tyr Tyr Phe Gin 850 855 860 Glu Gly Trp Asn He Phe Asp Phe He He Val Ala Leu Ser Leu Leu 865 870 875 880 Glu Leu Gly Leu Glu Gly Val Gin Gly Leu Ser Val Leu Arg Ser Phe 885 890 895 Arg Leu Leu Arg Val Phe Lys Leu Ala Lys Ser Trp Pro Thr Leu Asn 900 905 910 Leu Leu He Ser He Met Gly Arg Thr Met Gly Ala Leu Gly Asn Leu 915 920 925 Thr Phe Val Leu Cys He He He Phe He Phe Ala Val Met Gly Met 930 935 940 Gin Leu Phe Gly Lys Asn Tyr He Asp His Lys Asp Arg Phe Lys Asp 945 950 955 960 His Glu Leu Pro Arg Trp Asn Phe Thr Asp Phe Met His Ser Phe Met 965 970 975 He Val Phe Arg Val Leu Cys Gly Glu Trp He Glu Ser Met Trp Asp 980 985 990 Cys Met Tyr Val Gly Asp Val Ser Cys He Pro Phe Phe Leu Ala Thr 995 1000 1005 Val Val He Gly Asn Phe Val Val Leu Asn Leu Phe Leu Ala Leu Leu 1010 1015 1020 Leu Ser Asn Phe Gly Ser Ser Ser Leu Ser Ala Pro Thr Ala Asp Asn 1025 1030 1035 1040 Asp Thr Asn Lys He Ala Glu Ala Phe Asn Arg He Ala Arg Phe Lys 1045 1050 1055 Asn Trp Val Lys Arg Asn He Ala Asp Cys Phe Lys Leu He Arg Asn 1060 1065 1070 Lys Leu Thr Asn Gin He Ser Asp Gin Pro Ser Glu His Gly Asp Asn 1075 1080 1085 Glu Leu Glu Leu Gly His Asp Glu He Met Gly Asp Gly Leu He Lys 1090 1095 1100 Lys Gly Met Lys Gly Glu Thr Gin Leu Glu Val Ala He Gly Asp Gly 1105 1110 1115 1120 Met Glu Phe Thr He His Gly Asp Met Lys Asn Asn Lys Pro Lys Lys 1125 1130 1135 Ser Lys Phe He Asn Asn Thr Thr Met He Gly Asn Ser He Asn His 1140 1145 1150 Gin Asp Asn Arg Leu Glu His Glu Leu Asn His Arg Gly Leu Ser He 1155 1160 1165 Gin Asp Asp Asp Thr Ala Ser He Asn Ser Tyr Gly Ser His Lys Asn 1170 1175 1180 Arg Pro Phe Lys Asp Glu Ser His Lys Gly Ser Ala Glu Thr He Glu 1185 1190 1195 1200 Gly Glu Glu Lys Arg Asp Val Ser Lys Glu Asp Leu Gly Leu Asp Glu 1205 1210 1215 Glu Leu Asp Glu Glu Ala Glu Gly Asp Glu Gly Gin Leu Asp Gly Asp 1220 1225 1230 He He He His Ala Gin Asn Asp Asp Glu He He Asp Asp Tyr Pro 1235 1240 1245 Ala Asp Cys Phe Pro Asp Ser Tyr Tyr Lys Lys Phe Pro He Leu Ala 1250 1255 1260 Gly Asp Glu Asp Ser Pro Phe Trp Gin Gly Trp Gly Asn Leu Arg Leu 1265 1270 1275 1280 Lys Thr Phe Gin Leu He Glu Asn Lys Tyr Phe Glu Thr Ala Val He 1285 1290 1295 Thr Met He Leu Met Ser Ser Leu Ala Leu Ala Leu Glu Asp Val His 1300 1305 1310 Leu Pro Asp Arg Pro Val Met Gin Asp He Leu Tyr Tyr Met Asp Arg 1315 1320 1325 He Phe Thr Val He Phe Phe Leu Glu Met Leu He Lys Trp Leu Ala 1330 1335 1340 Leu Gly Phe Lys Val Tyr Phe Thr Asn Ala Trp Cys Trp Leu Asp Phe 1345 1350 1355 1360 Val He Val Met Leu Ser Leu He Asn Leu Val Ala Val Trp Ser Gly 1365 1370 1375 Leu Asn Asp He Ala Val Phe Arg Ser Met Arg Thr Leu Arg Ala Leu 1380 1385 1390 Arg Pro Leu Arg Ala Val Ser Arg Trp Glu Gly Met Lys Val Val Val 1395 1400 1405 Asn Ala Leu Val Gin Ala He Pro Ser He Phe Asn Val Leu Leu Val 1410 1415 1420 Cys Leu He Phe Trp Leu He Phe Ala He Met Gly Val Gin Leu Phe 1425 1430 1435 1440 Ala Gly Lys Tyr Phe Lys Cys Lys Asp Gly Asn Asp Thr Val Leu Ser 1445 1450 1455 His Glu He He Pro Asn Arg Asn Ala Cys Lys Ser Glu Asn Tyr Thr 1460 1465 1470 Trp Glu Asn Ser Ala Met Asn Phe Asp His Val Gly Asn Ala Tyr Leu 1475 1480 1485 Cys Leu Phe Gin Val Ala Thr Phe Lys Gly Trp He Gin He Met Asn 1490 1495 1500 Asp Ala He Asp Ser Arg Glu Val Asp Lys Gin Pro He Arg Glu Thr 1505 1510 1515 1520 Asn He Tyr Met Tyr Leu Tyr Phe Val Phe Phe He He Phe Gly Ser 1525 1530 1535 Phe Phe Thr Leu Asn Leu Phe He Gly Val He He Asp Asn Phe Asn 1540 1545 1550 Glu Gin Lys Lys Lys Ala Gly Gly Ser Leu Glu Met Phe Met Thr Glu 1555 1560 1565 Asp Gin Lys Lys Tyr Tyr Asn Ala Met Lys Lys Met Gly Ser Lys Lys 1570 1575 1580 Pro Leu Lys Ala He Pro Arg Pro Arg Trp Arg Pro Gin Ala He Val 1585 1590 1595 1600 Phe Glu He Val Thr Asp Lys Lys Phe Asp He He He Met Leu Phe 1605 1610 1615 He Gly Leu Asn Met Phe Thr Met Thr Leu Asp Arg Tyr Asp Ala Ser 1620 1625 1630 Glu Ala Tyr Asn Asn Val Leu Asp Lys Leu Asn Gly He Phe Val Val 1635 1640 1645 He Phe Ser Gly Glu Cys Leu Leu Lys He Phe Ala Leu Arg Tyr His 1650 1655 1660 Tyr Phe Lys Glu Pro Trp Asn Leu Phe Asp Val Val Val Val He Leu 1665 1670 1675 1680 Ser He Leu Gly Leu Val Leu Ser Asp He He Glu Lys Tyr Phe Val 1685 1690 1695 Ser Pro Thr Leu Leu Arg Val Val Arg Val Ala Lys Val Gly Arg Val 1700 1705 1710 Leu Arg Leu Val Lys Gly Ala Lys Gly He Arg Thr Leu Leu Phe Ala 1715 1720 1725 Leu Ala Met Ser Leu Pro Ala Leu Phe Asn He Cys Leu Leu Leu Phe 1730 1735 1740 Leu Val Met Phe He Phe Ala He Phe Gly Met Ser Phe Phe Met His 1745 1750 1755 1760 Val Lys Glu Lys Ser Gly He Asn Ala Val Tyr Asn Phe Lys Thr Phe 1765 1770 1775 Gly Gin Ser Met He Leu Leu Phe Gin Met Ser Thr Ser Ala Gly Trp 1780 1785 1790 Asp Gly Val Leu Asp Ala He He Asn Glu Glu Asp Cys Asp Pro Pro 1795 1800 1805 Asp Asn Asp Lys Gly Tyr Pro Gly Asn Cys Gly Ser Ala Thr Val Gly 1810 1815 1820 He Thr Phe Leu Leu Ser Tyr Leu Val He Ser Phe Leu He Val He 1825 1830 1835 1840 Asn Met Tyr He Ala Val He Leu Glu Asn Tyr Ser Gin Ala Thr Glu 1845 1850 1855 Asp Val Gin Glu Gly Leu Thr Asp Asp Asp Tyr Asp Met Tyr Tyr Glu 1860 1865 1870 He Trp Gin Gin Phe Asp Pro Glu Gly Thr Gin Tyr He Arg Tyr Asp 1875 1880 1885 Gin Leu Ser Glu Phe Leu Asp Val Leu Glu Pro Pro Leu Gin He His 1890 1895 1900 Lys Pro Asn Lys Tyr Lys He He Ser Met Asp Met Pro He Cys Arg 1905 1910 1915 1920 Gly Asp Met Met Tyr Cys Val Asp He Leu Asp Ala Leu Thr Lys Asp 1925 1930 1935 Phe Phe Ala Arg Lys Gly Asn Pro He Glu Glu Thr Gly Glu He Gly 1940 1945 1950 Glu He Ala Ala Arg Pro Asp Thr Glu Gly Tyr Asp Pro Val Ser Ser 1955 1960 1965 Thr Leu Trp Arg Gin Arg Glu Glu Tyr Cys Ala Lys Leu He Gin Asn 1970 1975 1980 Ala Trp Arg Arg Tyr Lys Asn Gly Pro Pro Gin Glu Gly Asp Glu Gly 1985 1990 1995 2000 Glu Ala Ala Gly Gly Glu Asp Gly Ala Glu Gly Gly Glu Gly Glu Gly 2005 2010 2015 Gly Ser Gly Gly Gly Gly Asp Asp Asp Gly Gly Ser Ala Thr Ala Ala 2020 2025 2030 Gly Ala Thr Ser Pro Thr Asp Pro Asp Ala Gly Glu Ala Asp Gly Ala 2035 2040 2045 Ser Ala Gly Asn Gly Gly Gly Pro Leu Ser Pro Gly Cys Val Ser Gly 2050 2055 2060 Gly Ser Asn Gly Arg Gin Thr Ala Val Leu Val Glu Ser Asp Gly Phe 2065 2070 2075 2080 Val Thr Lys Asn Gly His Lys Val Val He His Ser Arg Ser Pro Ser 2085 2090 2095 He Thr Ser Arg Thr Ala Asp Val 2100 ( 2 ) INFORMATION FOR SEQ ID NO : 5 : ( i ) SEQUENCE CHARACTERISTICS : (A) LENGTH : 18 base pairs (B ) TYPE : nucleic acid ( C ) STRANDEDNESS : single (D ) TOPOLOGY : linear (ii) MOLECULE TYPE: cDNA (xi ) SEQUENCE DESCRIPTION : SEQ ID NO : 5 : CGGTTGGGCT TTCCTGTC 18 (2) INFORMATION FOR SEQ ID NO : 6 : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 26 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA (xi ) SEQUENCE DESCRIPTION : SEQ ID NO : 6 : GGGAATTCCA ACATCTTCCA CCCCTC 26 (2) INFORMATION FOR SEQ ID NO: 7: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 23 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA (xi ) SEQUENCE DESCRIPTION : SEQ ID NO : 7 : CCCGACGACA TCGACCCCTA CTA 23 (2) INFORMATION FOR SEQ ID NO : 8 : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 18 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA (xi ) SEQUENCE DESCRIPTION : SEQ ID NO : 8 : CGTATCGCCT CCTCCTCG 18 (2) INFORMATION FOR SEQ ID NO : 9 : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 29 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA (xi ) SEQUENCE DESCRIPTION : SEQ ID NO : 9 : GGGTCTAGAT CTTCGCCATC TTCGGCATG 29 (2) INFORMATION FOR SEQ ID NO: 10: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 27 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA (xi ) SEQUENCE DESCRIPTION : SEQ ID NO : 10 : GGGGAATTCC GGCTCCAACT GCTGCCA 27 (2) INFORMATION FOR SEQ ID NO: 11: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 27 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA (xi ) SEQUENCE DESCRIPTION : SEQ ID NO : 11 : GGGTCTAGAC GACCACAACA ACTACTA 27 (2) INFORMATION FOR SEQ ID NO: 12: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 20 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear ( ii ) MOLECULE TYPE : cDNA (xi ) SEQUENCE DESCRIPTION : SEQ ID NO : 12 : TCATACTTTG GCCCAATGTC 20 (2) INFORMATION FOR SEQ ID NO:13: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 21 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA (xi ) SEQUENCE DESCRIPTION : SEQ ID NO : 13 : CCCGAATTAG AGAAGGTGCT G 21 (2) INFORMATION FOR SEQ ID NO: 14: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 21 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA (xi ) SEQUENCE DESCRIPTION : SEQ ID NO : 14 : ACTATTGCTT GTGGTCGCCA C 21 (2) INFORMATION FOR SEQ ID NO: 15: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 25 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA (xi ) SEQUENCE DESCRIPTION : SEQ ID NO : 15 : CATCCTTCGC CGCCTAGACC ATGAC 25 (2) INFORMATION FOR SEQ ID NO: 16: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 21 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA (xi ) SEQUENCE DESCRIPTION : SEQ ID NO : 16 : GATTGAATGG ATCGAGCAGC C 21 (2) INFORMATION FOR SEQ ID NO: 17: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 21 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA (xi ) SEQUENCE DESCRIPTION : SEQ ID NO : 17 : CGTTTCTCCT TTCATATCTA G 21 (2) INFORMATION FOR SEQ ID NO:18: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 25 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA (xi ) SEQUENCE DESCRIPTION : SEQ ID NO : 18 : GGAGCGGCGG CCCCGGCCCC GCTCA 25 (2) INFORMATION FOR SEQ ID NO: 19: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 2100 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: not relevant (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 19: Met Thr Glu Asp Ser Asp Ser He Ser Glu Glu Glu Arg Ser Leu Phe 1 5 10 15 Arg Pro Phe Thr Arg Glu Ser Leu Val Gin He Glu Gin Arg He Ala 20 25 30 Ala Glu His Glu Lys Gin Lys Glu Leu Glu Arg Lys Arg Ala Glu Gly 35 40 45 Glu Val Pro Arg Tyr Gly Arg Lys Lys Lys Gin Lys Glu He Arg Tyr 50 55 60 Asp Asp Glu Asp Glu Asp Glu Gly Pro Gin Pro Asp Pro Thr Leu Glu 65 70 75 80 Gin Gly Val Pro He Pro Val Arg Leu Gin Gly Ser Phe Pro Pro Glu 85 90 95 Leu Ala Ser Thr Pro Leu Glu Asp He Asp Pro Tyr Tyr Ser Asn Val 100 105 110 Leu Thr Phe Val Val Val Ser Lys Gly Lys Asp He Phe Arg Phe Ser 115 120 125 Ala Ser Lys Ala Met Trp Met Leu Asp Pro Phe Asn Pro He Arg Arg 130 135 140 Val Ala He Tyr He Leu Val His Pro Leu Phe Ser Leu Phe lie He 145 150 155 160 Thr Thr He Leu Val Asn Cys He Leu Met He Met Pro Thr Thr Pro 165 170 175 Thr Val Glu Ser Thr Glu Val He Phe Thr Gly He Tyr Thr Phe Glu 180 185 190 Ser Ala Val Lys Val Met Ala Arg Gly Phe He Leu Cys Pro Phe Thr 195 200 205 Tyr Leu Arg Asp Ala Trp Asn Trp Leu Asp Phe Val Val He Ala Leu 210 215 220 Ala Tyr Val Thr Met Gly He Asp Leu Gly Asn Leu Ala Ala Leu Arg 225 230 235 240 Thr Phe Arg Val Leu Arg Ala Leu Lys Thr Val Ala He Val Pro Gly 245 250 255 Leu Lys Thr He Val Gly Ala Val He Glu Ser Val Lys Asn Leu Arg 260 265 270 Asp Val He He Leu Thr Met Phe Ser Leu Ser Val Phe Ala Leu Met 275 280 285 Gly Leu Gin He Tyr Met Gly Val Leu Thr Glu Lys Cys He Lys Lys 290 295 300 Phe Pro Leu Asp Gly Ser Trp Gly Asn Leu Thr Asp Glu Asn Trp Asp 305 310 315 320 Tyr His Asn Arg Asn Ser Ser Asn Trp Tyr Ser Glu Asp Glu Gly He 325 330 335 Ser Phe Pro Leu Cys Gly Asn He Ser Gly Ala Gly Gin Cys Asp Asp 340 345 350 Asp Tyr Val Cys Leu Gin Gly Phe Gly Pro Asn Pro Asn Tyr Gly Tyr 355 360 365 Thr Ser Phe Asp Ser Phe Gly Trp Ala Phe Leu Ser Ala Phe Arg Leu 370 375 380 Met Thr Gin Asp Phe Trp Glu Asp Leu Tyr Gin Leu Val Leu Arg Ala 385 390 395 400 Ala Gly Pro Trp His Met Leu Phe Phe He Val He He Phe Leu Gly 405 410 415 Ser Phe Tyr Leu Val Asn Leu He Leu Ala He Val Ala Met Ser Tyr 420 425 430 Asp Glu Leu Gin Arg Lys Ala Glu Glu Glu Glu Ala Ala Glu Glu Glu 435 440 445 Ala He Arg Glu Ala Glu Glu Ala Ala Ala Ala Lys Ala Ala Lys Leu 450 455 460 Glu Glu Arg Ala Asn Ala Gin Ala Gin Ala Ala Ala Asp Ala Ala Ala 465 470 475 480 Ala Glu Glu Ala Ala Leu His Pro Glu Met Ala Lys Ser Pro Thr Tyr 485 490 495 Ser Cys He Ser Tyr Glu Leu Phe Val Gly Gly Glu Lys Gly Asn Asp 500 505 510 Asp Asn Asn Lys Glu Lys Met Ser He Arg Ser Val Glu Val Glu Ser 515 520 525 Glu Ser Val Ser Val He Gin Arg Gin Pro Ala Pro Thr Thr Ala His 530 535 540 Gin Ala Thr Lys Val Arg Lys Val Ser Thr Thr Ser Leu Ser Leu Pro 545 550 555 560 Gly Ser Pro Phe Asn He Arg Arg Gly Ser Arg Ser Ser His Lys Tyr 565 570 575 Thr He Arg Asn Gly Arg Gly Arg Phe Gly He Pro Gly Ser Asp Arg 580 585 590 Lys Pro Leu Val Leu Ser Thr Tyr Gin Asp Ala Gin Gin His Leu Pro 595 600 605 Tyr Ala Asp Asp Ser Asn Ala Val Thr Pro Met Ser Glu Glu Asn Gly 610 615 620 Ala He He Val Pro Val Tyr Tyr Gly Asn Leu Gly Ser Arg His Ser 625 630 635 640 Ser Tyr Thr Ser His Gin Ser Arg He Ser Tyr Thr Ser His Gly Asp 645 650 655 Leu Leu Gly Gly Met Ala Val Met Gly Val Ser Thr Met Thr Lys Glu 660 665 670 Ser Lys Leu Arg Asn Arg Asn Thr Arg Asn Gin Ser Val Gly Ala Thr 675 680 685 Asn Gly Gly Thr Thr Cys Leu Asp Thr Asn His Lys Leu Asp His Arg 690 695 700 Asp Tyr Glu He Gly Leu Glu Cys Thr Asp Glu Ala Gly Lys He Lys 705 710 715 720 His His Asp Asn Pro Phe He Glu Pro Val Gin Thr Gin Thr Val Val 725 730 735 Asp Met Lys Asp Val Met Val Leu Asn Asp He He Glu Gin Ala Ala 740 745 750 Gly Arg His Ser Arg Ala Ser Asp Arg Gly Glu Asp Asp Asp Glu Asp 755 760 765 Gly Pro Thr Phe Lys Asp Lys Ala Leu Glu Val He Leu Lys Gly He 770 775 780 Asp Val Phe Cys Val Trp Asp Cys Cys Trp Val Trp Leu Lys Phe Gin 785 790 795 800 Glu Trp Val Ser Leu He Val Phe Asp Pro Phe Val Glu Leu Phe He 805 810 815 Thr Leu Cys He Val Val Asn Thr Met Phe Met Ala Met Asp His His 820 825 830 Asp Met Asn Lys Glu Met Glu Arg Val Leu Lys Ser Gly Asn Tyr Phe 835 840 845 Phe Thr Ala Thr Phe Ala He Glu Ala Thr Met Lys Leu Met Ala Met 850 855 860 Ser Pro Lys Tyr Tyr Phe Gin Glu Gly Trp Asn He Phe Asp Phe He 865 870 875 880 He Val Ala Leu Ser Leu Leu Glu Leu Gly Leu Glu Gly Val Gin Gly 885 890 895 Leu Ser Val Leu Arg Ser Phe Arg Leu Leu Arg Val Phe Lys Leu Ala 900 905 910 Lys Ser Trp Pro Thr Leu Asn Leu Leu He Ser He Met Gly Arg Thr 915 920 925 Met Gly Ala Leu Gly Asn Leu Thr Phe Val Leu Cys He He He Phe 930 935 940 He Phe Ala Val Met Gly Met Gin Leu Phe Gly Lys Asn Tyr His Asp 945 950 955 960 His Lys Asp Arg Phe Pro Asp Gly Asp Leu Pro Arg Trp Asn Phe Thr 965 970 975 Asp Phe Met His Ser Phe Met He Val Phe Arg Val Leu Cys Gly Glu 980 985 990 Trp He Glu Ser Met Trp Asp Cys Met Tyr Val Gly Asp Val Ser Cys 995 1000 1005 He Pro Phe Phe Leu Ala Thr Val Val He Gly Asn Leu Val Val Leu 1010 1015 1020 Asn Leu Phe Leu Ala Leu Leu Leu Ser Asn Phe Gly Ser Ser Ser Leu 1025 1030 1035 1040 Ser Ala Pro Thr Ala Asp Asn Asp Thr Asn Lys He Ala Glu Ala Phe 1045 1050 1055 Asn Arg He Gly Arg Phe Lys Ser Trp Val Lys Arg Asn He Ala Asp 1060 1065 1070 Cys Phe Lys Leu He Arg Asn Lys Leu Thr Asn Gin He Ser Asp Gin 1075 1080 1085 Pro Ser Glu His Gly Asp Asn Glu Leu Glu Leu Gly His Asp Glu He 1090 1095 1100 Leu Ala Asp Gly Leu He Lys Lys Gly He Lys Glu Gin Thr Gin Leu 1105 1110 1115 1120 Glu Val Ala He Gly Asp Gly Met Glu Phe Thr He His Gly Asp Met 1125 1130 1135 Lys Asn Asn Lys Pro Lys Lys Ser Lys Tyr Leu Asn Asn Ala Thr Asp 1140 1145 1150 Asp Asp Thr Ala Ser He Asn Ser Tyr Gly Ser His Lys Asn Arg Pro 1155 1160 1165 Phe Lys Asp Glu Ser His Lys Gly Ser Ala Glu Thr Met Glu Gly Glu 1170 1175 1180 Glu Lys Arg Asp Ala Ser Lys Glu Asp Leu Gly Leu Asp Glu Glu Leu 1185 1190 1195 1200 Asp Glu Glu Gly Glu Cys Glu Glu Gly Pro Leu Asp Gly Asp He He 1205 1210 1215 He His Ala His Asp Glu Asp He Leu Asp Glu Tyr Pro Ala Asp Cys 1220 1225 1230 Cys Pro Asp Ser Tyr Tyr Lys Lys Phe Pro He Leu Ala Gly Asp Asp 1235 1240 1245 Asp Ser Pro Phe Trp Gin Gly Trp Gly Asn Leu Arg Leu Lys Thr Phe 1250 .255 1260 Arg Leu He Glu Asp Lys Tyr Phe Glu Thr Ala Val He Thr Met He 1265 1270 1275 1280 Leu Met Ser Ser Leu Ala Leu Ala Leu Glu Asp Val His Leu Pro Gin 1285 1290 1295 Arg Pro He Leu Gin Asp He Leu Tyr Tyr Met Asp Arg He Phe Thr 1300 1305 1310 Val He Phe Phe Leu Glu Met Leu He Lys Trp Leu Ala Leu Gly Phe 1315 1320 1325 Lys Val Tyr Leu Thr Asn Ala Trp Cys Trp Leu Asp Phe Val He Val 1330 1335 1340 Met Val Ser Leu He Asn Phe Val Ala Ser Leu Val Gly Ala Gly Gly 1345 1350 1355 1360 He Gin Ala Phe Lys Thr Met Arg Thr Leu Arg Ala Leu Arg Pro Leu 1365 1370 1375 Arg Ala Met Ser Arg Met Gin Gly Met Arg Val Val Val Asn Ala Leu 1380 1385 1390 Val Gin Ala He Pro Ser He Phe Asn Val Leu Leu Val Cys Leu He 1395 1400 1405 Phe Trp Leu He Phe Ala He Met Gly Val Gin Leu Phe Ala Gly Lys 1410 1415 1420 Tyr Phe Lys Cys Glu Asp Met Asn Gly Thr Lys Leu Ser His Glu He 1425 1430 1435 . 1440 He Pro Asn Arg Asn Ala Cys Glu Ser Glu Asn Tyr Thr Trp Val Asn 1445 1450 1455 Ser Ala Met Asn Phe Asp His Val Gly Asn Ala Tyr Leu Cys Leu Phe 1460 1465 1470 Gin Val Ala Thr Phe Lys Gly Trp He Gin He Met Asn Asp Ala He 1475 1480 1485 Asp Ser Arg Glu Val Asp Lys Gin Pro He Arg Glu Thr Asn lie Tyr 1490 1495 1500 Met Tyr Leu Tyr Phe Val Phe Phe He He Phe Gly Ser Phe Phe Thr 1505 1510 1515 1520 Leu Asn Leu Phe He Gly Val He He Asp Asn Phe Asn Glu Gin Lys 1525 1530 1535 Lys Lys Ala Gly Gly Ser Leu Glu Met Phe Met Thr Glu Asp Gin Lys 1540 1545 1550 Lys Tyr Tyr Ser Ala Met Lys Lys Met Gly Ser Lys Lys Pro Leu Lys 1555 1560 1565 Ala He Pro Arg Pro Arg Trp Arg Pro Gin Ala He Val Phe Glu He 1570 1575 1580 Val Thr Asp Lys Lys Phe Asp He He He Met Leu Phe He Gly Leu 1585 1590 1595 1600 Asn Met Phe Thr Met Thr Leu Asp Arg Tyr Asp Ala Ser Asp Thr Tyr 1605 1610 1615 Asn Ala Val Leu Asp Tyr Leu Asn Ala He Phe Val Val He Phe Ser 1620 1625 1630 Ser Glu Cys Leu Leu Lys He Phe Ala Leu Arg Tyr His Tyr Phe He 1635 1640 1645 Glu Pro Trp Asn Leu Phe Asp Val Val Val Val He Leu Ser He Leu 1650 1655 1660 Gly Leu Val Leu Ser Asp He He Glu Lys Tyr Phe Val Ser Pro Thr 1665 1670 1675 1680 Leu Leu Arg Val Val Arg Val Ala Lys Val Gly Arg Val Leu Arg Leu 1685 1690 1695 Val Lys Gly Ala Lys Gly He Arg Thr Leu Leu Phe Ala Leu Ala Met 1700 1705 1710 Ser Leu Pro Ala Leu Phe Asn He Cys Leu Leu Leu Phe Leu Val Met 1715 1720 1725 Phe He Phe Ala He Phe Gly Met Ser Phe Phe Met His Val Lys Glu 1730 1735 1740 Lys Ser Gly He Asn Asp Val Tyr Asn Phe Lys Thr Phe Gly Gin Ser 1745 1750 1755 1760 Met He Leu Leu Phe G n Met Ser Thr Ser Ala Gly Trp Asp Gly Val 1765 1770 1775 Leu Asp Ala He He Asn Glu Glu Ala Cys Asp Pro Pro Asp Asn Asp 1780 1785 1790 Lys Gly Tyr Pro Gly Asn Cys Gly Ser Ala Thr Val Gly He Thr Phe 1795 1800 1805 Leu Leu Ser Tyr Leu Val He Ser Phe Leu He Val He Asn Met Tyr 1810 1815 1820 He Ala Val He Leu Glu Asn Tyr Ser Gin Ala Thr Glu Asp Val Gin 1825 1830 1835 1840 Glu Gly Leu Thr Asp Asp Asp Tyr Asp Met Tyr Tyr Glu He Trp Gin 1845 1850 1855 Gin Phe Asp Pro Glu Gly Thr Gin Tyr He Arg Tyr Asp Gin Leu Ser 1860 1865 1870 Glu Phe Leu Asp Val Leu Glu Pro Pro Leu Gin He His Lys Pro Asn 1875 1880 1885 Lys Tyr Lys He He Ser Met Asp He Pro He Cys Arg Gly Asp Leu 1890 1895 1900 Met Tyr Cys Val Asp He Leu Asp Ala Leu Thr Lys Asp Phe Phe Ala 1905 1910 1915 1920 Arg Lys Gly Asn Pro He Glu Glu Thr Gly Glu He Gly Glu He Ala 1925 1930 1935 Ala Arg Pro Asp Thr Glu Gly Tyr Glu Pro Val Ser Ser Thr Leu Trp 1940 1945 1950 Arg Gin Arg Glu Glu Tyr Cys Ala Arg Leu He Gin His Ala Trp Arg 1955 1960 1965 Lys His Lys Ala Arg Gly Glu Gly Gly Gly Ser Phe Glu Pro Asp Thr 1970 1975 1980 Asp His Gly Asp Gly Gly Asp Pro Asp Ala Gly Asp Pro Ala Pro Asp 1985 1990 1995 2000 Glu Ala Thr Asp Gly Asp Ala Pro Ala Gly Gly Asp Gly Ser Val Asn 2005 2010 2015 Gly Thr Ala Glu Gly Ala Ala Asp Ala Asp Glu Ser Asn Val Asn Ser 2020 2025 2030 Pro Gly Glu Asp Ala Ala Ala Ala Ala Ala Ala Ala Ala Ala Ala Ala 2035 2040 2045 Ala Ala Gly Thr Thr Thr Ala Gly Ser Pro Gly Ala Gly Ser Ala Gly 2050 2055 2060 Arg Gin Thr Ala Val Leu Val Glu Ser Asp Gly Phe Val Thr Lys Asn 2065 2070 2075 2080 Gly His Lys Val Val He His Ser Arg Ser Pro Ser He Thr Ser Arg 2085 2090 2095 Thr Ala Asp Val 2100

Claims: WHAT IS CLAIMED IS: 1. An isolated nucleic acid molecule encoding a voltage-sensitive sodium channel of Musca domestica, wherein said voltage-sensitive sodium channel is capable of conferring sensitivity or resistance to an insecticide in Musca domestica . 2. The isolated nucleic acid molecule of claim 1 wherein said nucleic acid is deoxyribonucleic acid. 3. The isolated nucleic acid molecule of claim 2 wherein said deoxyribonucleic acid is cDNA. 4. The isolated nucleic acid molecule of claim 1 wherein said voltage-sensitive sodium channel confers susceptibility to an insecticide in Musca domestica . 5. The isolated nucleic acid molecule of claim 4 wherein said nucleic acid molecule has a nucleotide sequence as shown in SEQ ID N0:1. 6. The isolated nucleic acid molecule of claim 4 wherein said nucleic acid molecule encodes an amino acid sequence as shown in SEQ ID NO: 3. 7. The isolated nucleic acid molecule of claim 1 wherein said voltage-sensitive sodium channel confers resistance to an insecticide in Musca domestica . 8. The isolated nucleic acid molecule of claim 7 wherein said nucleic acid molecule has a nucleotide sequence as shown in SEQ ID NO: 2. 9. The isolated nucleic acid molecule of claim 7 wherein said nucleic acid molecule encodes an amino acid sequence as shown in SEQ ID NO: 4. 10. The isolated nucleic acid molecule of claim 7 wherein said nucleic acid molecule has the nucleotide sequence of a second nucleic acid molecule with one or more mutations therein, wherein said second nucleic acid molecule encodes an insecticide sensitive voltage- sensitive sodium channel of Musca domestica, and wherein said one or more mutations in said second nucleic acid molecule render the resulting voltage-sensitive sodium channel resistant to an insecticide. 11. The isolated nucleic acid molecule of claim 10 wherein said nucleotide sequence of said second nucleic acid molecule encodes amino acid SEQ ID NO: 3, and wherein said one or more mutations in said second nucleic acid molecule are selected from the group consisting of a substitution for amino acid residue 1014 of SEQ ID NO: 3, a substitution for amino acid residue 1140 of SEQ ID NO : 3 , a substitution for amino acid residue 2023 of SEQ ID NO: 3, a deletion of one or more of amino acid residues 2031-2034 of SEQ ID NO:3, a substitution for amino acid residue 2042 of SEQ ID NO: 3, a substitution for amino acid residue 2054 of SEQ ID NO: 3, and an insertion of one to three amino acid residues between amino acid residues 2055 and 2056 of SEQ ID NO: 3. 12. The isolated nucleic acid molecule of claim 1 wherein said nucleic acid is ribonucleic acid. 13. The isolated nucleic acid molecule of claim 12 wherein said ribonucleic acid is mRNA. 14. An antisense nucleic acid molecule complementary to at least a portion of the mRNA of claim 13. 15. An expression vector comprising the antisense nucleic acid molecule of claim 14. 16. The expression vector of claim 15 wherein the expression vector is a baculovirus. 17. A method of decreasing expression of a voltage-sensitive sodium channel in an insect, said method comprising infecting an insect with the baculovirus vector of claim 16, wherein infection of said insect by said baculovirus results in incorporation of said antisense nucleic acid molecule into the genome of said insect, thereby blocking expression of voltage-sensitive sodium channels in said insect cell. 18. A ribozyme having a recognition sequence complementary to a portion of the mRNA of claim 13. 19. An expression vector comprising the ribozyme of claim 18. 20. The expression vector of claim 19 wherein the expression vector is a baculovirus. 21. A method of decreasing expression of a voltage-sensitive sodium channel in an insect, said method comprising infecting an insect with the baculovirus vector of claim 20, wherein infection of said insect by said baculovirus results in expression of said ribozyme in said insect, thereby decreasing expression of voltage-sensitive sodium channels in said insect cell. 22. A cell comprising the nucleic acid molecule of claim 1. 23. The cell of claim 22 wherein the eell is a Xenopus oocyte. 24. The cell of claim 22 wherein the cell is an insect cell line. 25. The cell of claim 24 wherein said insect cell line is selected from the group consisting of a Drosophila Schneider cell line, a Drosophila K c cell line, an Sf9 cell line, and a High Five ® cell line. 26. An expression vector comprising the nucleic acid molecule of claim 1. 27. The expression vector of claim 26 wherein said expression vector is selected from the group consisting of a plasmid and a virus. 28. A cell comprising the expression vector of claim 26. 29. The cell of claim 28 wherein the cell is a Xenopus oocyte . 30. The cell of claim 28 wherein the cell is an insect cell line. 31. The cell of claim 30 wherein said insect cell line is selected from the group consisting of a Drosophila Schneider cell line, a Drosophila K c cell line, an Sf9 cell line, and a High Five ® cell line. 32. The isolated nucleic acid molecule of claim 1 wherein said insecticide is selected from the group consisting of DDT, DDT analogs, and pyrethroids . 33. A method of producing a voltage-sensitive sodium channel, said method comprising: introducing the nucleic acid molecule of claim 1 into a cell; and allowing said cell to express said nucleic acid molecule resulting in the production of a voltage- sensitive sodium channel in said cell. 34. The method of claim 33 wherein the cell is a Xenopus oocyte . 35. The method of claim 33 wherein the cell is an insect cell line. 36. The method of claim 35 wherein said insect cell line is selected from the group consisting of a Drosophila Schneider cell line, a Drosophila K c cell line, an Sf9 cell line, and a High Five ® cell line. 37. A method of producing a voltage-sensitive sodium channel, said method comprising: introducing the nucleic acid molecule of claim 1 and a second nucleic acid molecule encoding a tip E protein into a cell; and allowing said cell to coexpress said nucleic acid molecule and said second nucleic acid molecule, resulting in the production of a voltage- sensitive sodium channel in said cell. 38. The method of claim 37 wherein the cell is a Xenopus oocyte . 39. The method of claim 37 wherein the cell is an insect cell line. 40. The method of claim 39 wherein said insect cell line is selected from the group consisting of a Drosophila Schneider cell line, a Drosophila K c cell line, an Sf9 cell line, and a High Five ® cell line. 41. A method of screening a chemical agent for the ability of the chemical agent to modify sodium channel function, said method comprising: introducing the nucleic acid molecule of claim 1 into a host cell; expressing said voltage-sensitive sodium channel encoded by said nucleic acid molecule in the host cell so as to result in the functional expression of a voltage-sensitive sodium channel in the host cell; exposing the cell to a chemical agent; and evaluating the exposed cell to determine if the chemical agent modifies the function of the voltage- sensitive sodium channel. 42. The method of claim 41 wherein the cell is a Xenopus oocyte . 43. The method of claim 41 wherein the cell is an insect cell line. 44. The method of claim 43 wherein said insect cell line is selected from the group consisting of a Drosophila Schneider cell line, a Drosophila K c cell line, an Sf9 cell line, and a High Five ® cell line. 45. The method of claim 41 wherein said evaluation comprises monitoring sodium transport through said voltage-sensitive sodium channel. 46. The method of claim 41 wherein said evaluation comprises monitoring quanidinium transport through said voltage-sensitive sodium channel. 47. A method of screening a chemical agent for the ability of the chemical agent to modify sodium channel function, said method comprising: introducing the nucleic acid molecule of claim 1 and a second nucleic acid molecule encoding a tip E protein into a host cell; allowing said host cell to coexpress said nucleic acid molecule and said second nucleic acid molecule so as to result in the functional expression of a voltage-sensitive sodium channel in the host cell; exposing the cell to a chemical agent; and evaluating the exposed cell to determine if the chemical agent modifies the function of the voltage- sensitive sodium channel . 48. The method of claim 47 wherein the cell is a Xenopus oocyte . 49. The method of claim 47 wherein the cell is an insect cell line. 50. The method of claim 49 wherein said insect cell line is selected from the group consisting of a Drosophila Schneider cell line, a Drosophila K c cell line, an Sf9 cell line, and a High Five ® cell line. 51. The method of claim 47 wherein said evaluation comprises monitoring sodium transport through said voltage-sensitive sodium channel. 52. The method of claim 47 wherein said evaluation comprises monitoring quanidinium transport through said voltage-sensitive sodium channel. 53. A method of obtaining DNA encoding a voltage-sensitive sodium channel, said method comprising: selecting a DNA molecule encoding a voltage-sensitive sodium channel of an insect, said DNA molecule having a nucleotide sequence selected from the group consisting of SEQ ID N0:1 and SEQ ID NO: 2; designing an oligonucleotide probe for a voltage-sensitive sodium channel based on SEQ ID N0:1 or SEQ ID NO: 2; probing a genomic or cDNA library of an insect with the oligonucleotide probe; and obtaining clones from said library that are recognized by said oligonucleotide probe, so as to obtain DNA encoding a voltage-sensitive sodium channel. 54. A method of obtaining DNA encoding a voltage-sensitive sodium channel, said method comprising: selecting a DNA molecule encoding a voltage-sensitive sodium channel of an insect, said DNA molecule having a nucleotide sequence selected from the group consisting of SEQ ID N0:1 and SEQ ID NO: 2; designing degenerate oligonucleotide primers based on SEQ ID NO:l or SEQ ID NO : 2 ; and utilizing said oligonucleotide primers in a polymerase chain reaction on a DNA sample to identify homologous DNA encoding a voltage-sensitive sodium channel in said sample. 55. An isolated nucleic acid molecule encoding a voltage-sensitive sodium channel of an insect, said nucleic acid molecule encoding a first amino acid sequence having at least 95% amino acid identity to a second amino acid sequence, said second amino acid sequence being as shown in SEQ ID NO : 3. 56. An isolated nucleic acid molecule encoding a voltage-sensitive sodium channel of an insect, said nucleic acid molecule encoding a first amino acid sequence having at least 95% amino acid identity to a second amino acid sequence, said second amino acid sequence being as shown in SEQ ID NO : 4. 57. An isolated voltage-sensitive sodium channel of Musca domestica , wherein said voltage-sensitive sodium channel is capable of conferring sensitivity or resistance to an insecticide in Musca domestica . 58. The voltage-sensitive sodium channel of claim 57 wherein said voltage-sensitive sodium channel confers susceptibility to an insecticide in Musca domestica . 59. The voltage-sensitive sodium channel of claim 58 wherein said voltage-sensitive sodium channel is encoded by a nucleotide sequence as shown in SEQ ID N0:1. 60. The voltage-sensitive sodium channel of claim 58 wherein said voltage-sensitive sodium channel is comprised of a protein having an amino acid sequence as shown in SEQ ID NO : 3. 61. The voltage-sensitive sodium channel of claim 57 wherein said voltage-sensitive sodium channel confers resistance to an insecticide in Musca domestica . 62. The voltage-sensitive sodium channel of claim 61 wherein said voltage-sensitive sodium channel is encoded by a nucleotide sequence as shown in SEQ ID NO : 2. • 63. The voltage-sensitive sodium channel of claim 61 wherein said voltage-sensitive sodium channel is comprised of a protein having an amino acid sequence as shown in SEQ ID NO : 4. 64. The voltage-sensitive sodium channel of claim 61 wherein said voltage-sensitive sodium channel is encoded by a nucleic acid molecule having the nucleotide sequence of a second nucleic acid molecule with one or more mutations therein, wherein said second nucleic acid molecule encodes an insecticide sensitive voltage- sensitive sodium channel of Musca domestica, and wherein said one or more mutations in said second nucleic acid molecule render the resulting voltage-sensitive sodium channel resistant to an insecticide. 65. The voltage-sensitive sodium channel of claim 64 wherein said nucleotide sequence of said second nucleic acid molecule encodes amino acid SEQ ID NO: 3, and wherein said one or more mutations in said second nucleic acid molecule are selected from the group consisting of a substitution for amino acid residue 1014 of SEQ ID NO: 3, a substitution for amino acid residue 1140 of SEQ ID NO: 3, a substitution for amino acid residue 2023 of SEQ ID NO: 3, a deletion of one or more of amino acid residues 2031-2034 of SEQ ID NO: 3, a substitution for amino acid residue 2042 of SEQ ID NO: 3, a substitution for amino acid residue 2054 of SEQ ID NO: 3, and an insertion of one to three amino acid residues between amino acid residues 2055 and 2056 of SEQ ID NO: 3. 66. The voltage-sensitive sodium channel of claim 57 wherein said insecticide is selected from the group consisting of DDT, DDT analogs, and pyrethroids . 67. An antibody or fragment thereof specific for the voltage-sensitive sodium channel of claim 57. 68. The antibody of claim 67 wherein said antibody comprises a monoclonal antibody. 69. The antibody of claim 67 wherein said antibody comprises a polyclonal antibody. 70. A method of detecting presence of a voltage-sensitive sodium channel in a sample, said method comprising: contacting a sample with the antibody or fragment thereof of claim 67, wherein said antibody or fragment thereof binds to any of said voltage-sensitive sodium channel present in said sample, forming a complex therewith; and detecting said complex, thereby detecting presence of a voltage-sensitive sodium channel in said sample . 71. An isolated voltage-sensitive sodium channel of Musca domestica, wherein the voltage-sensitive sodium channel is comprised of a protein having a first amino acid sequence with at least 95% amino acid identity to a second amino acid sequence, said second amino acid sequence being as shown in SEQ ID NO: 3. 72. An isolated voltage-sensitive sodium channel of Musca domestica, wherein the voltage-sensitive sodium channel is comprised of a protein having a first amino acid sequence with at least 95% amino acid identity to a second amino acid sequence, said second amino acid sequence being as shown in SEQ ID N0:4. 73. A plasmid designated pPJIl and deposited with the American Type Culture Collection under Accession No. 97831. 74. A Kpnl/Aatll restriction fragment of the plasmid designated pPJIl of claim 73, said restriction fragment being about 3620 bp. 75. A plasmid designated pPJI2 and deposited with the American Type Culture Collection under Accession No. 97832. 76. An Aatll/Sphll restriction fragment of the plasmid designated pPJI2 of claim 75, said restriction fragment being about 2700 bp. 77. An isolated nucleic acid molecule consisting of a Kpnl/Aatll restriction fragment of about 3620 bp of the plasmid designated pPJIl ligated at the Aatll site to the Aatll site of an Aatll/Sphll restriction fragment of about 2700 bp of the plasmid designated pPJI2.

Inventors: INGLES PATRICIA J, KNIPPLE DOUGLAS C, SODERLUND DAVID M, INGLES, PATRICIA, J., KNIPPLE, DOUGLAS, C., SODERLUND, DAVID, M.
Applicants: CORNELL RES FOUNDATION INC, CORNELL RESEARCH FOUNDATION, INC.
Application year: 1997
Main classification: C12Q1
IPC codes: C07K14, C12N15